UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

DEFINITIVE
SCHEDULE 14C
INFORMATION STATEMENT PURSUANT TO SECTION 14(C)
OF THE SECURITIES EXCHANGE ACT OF 1934

Check the appropriate box:
 [_]  Preliminary Information Statement
 [_]  Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2))
 [X]  Definitive Information Statement

CHINA BIOTECH HOLDINGS LIMITED
(Name of Registrant as Specified in its Charter)

Payment of Filing Fee (Check the appropriate box):
 [X]  No fee required
 [_]  Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11
(1)  Title of each class of securities to which transaction applies:  ___________________
(2)  Aggregate number of securities to which transaction applies:  ___________________
(3)  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):  ___________________
(4)  Proposed maximum aggregate value of transaction:  _______________
(5)  Total fee paid:  $___________________
 [_]  Fee paid previously with preliminary materials.
 [_]  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1)  Amount Previously Paid:
(2)  Form, Schedule or Registration Statement No.:
(3)  Filing Party:
(4)  Date Filed:
 
 


CHINA BIOTECH HOLDINGS LIMITED
Suite 2432, Sun Hung Kai Centre
30 Harbour Road
Wanchai, Hong Kong
\

INFORMATION STATEMENT

January 16, 2018

GENERAL

This Information Statement is furnished on or about January 16, 2018 to the holders of record of the outstanding common stock, $0.0001 par value (the "Common Stock") of China Biotech Holdings Limited, a Delaware corporation (the "Company"), as of the close of business on November 15, 2017 (the "Record Date"), pursuant to Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

This Information Statement relates to a written consent in lieu of a meeting, dated November 15, 2017 (the "Written Consent"), of stockholders of the Company owning all of the outstanding shares of Common Stock of the Company, as of the Record Date (the "Majority Stockholders"). Except as otherwise indicated by the context, references in this Information Statement to "Company," "we," "us," or "our" are references to China Biotech Holdings, Limited.
 
The Written Consent approved a change of domicile from the State of Delaware to the Cayman Islands by means of the merger (the "Redomicile Merger") of the Company with and into Zhong Yuan Bio-Technology Holdings Limited, an exempt company limited by shares which is incorporated under the laws of the Cayman Islands ("Zhong Yuan"), including approval of the Agreement and Plan of Merger, a copy of which is attached hereto as Annex A (the "Merger Agreement") and all the transactions contemplated by the Plan of Merger, the form of which is attached to the Merger Agreement as Annex A thereto (the "Plan of Merger"). Pursuant to the Merger Agreement, the Company will merge with and into Zhong Yuan and each share of the Company's Common Stock will be converted into one ordinary share of Zhong Yuan.
 
These corporate actions will become effective on the date the Plan of Merger is registered by the Registrar of Companies of the Cayman Islands, which will occur at least 20 days after the date of the mailing of this Information Statement to our stockholders.

The Company will pay the cost of preparing, printing and distributing this Information Statement.

PLEASE NOTE THAT THIS IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS AND NO STOCKHOLDERS MEETING WILL BE HELD TO CONSIDER THE MATTERS DESCRIBED HEREIN. THIS INFORMATION STATEMENT IS BEING FURNISHED TO YOU SOLELY FOR THE PURPOSE OF INFORMING STOCKHOLDERS OF THE MATTERS DESCRIBED HEREIN PURSUANT TO SECTION 14(C) OF THE EXCHANGE ACT AND THE REGULATIONS PROMULGATED THEREUNDER, INCLUDING REGULATION 14C.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
 
By Order of the Board of Directors,
 
/s/ CHANG Ting Ting
 
CHANG Ting Ting
 
Chief Executive Officer
 




AUTHORIZATION BY THE BOARD OF DIRECTORS AND THE STOCKHOLDERS
 
Under the Delaware General Corporation Law ("DGCL") and the Company's Bylaws, any action that can be taken at an annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted consent to such action in writing. The approval of the Redomicile Merger requires the affirmative vote or written consent of a majority of the voting power of the issued and outstanding shares of Common Stock. Each stockholder is entitled to one vote per share of Common Stock held of record on any matter which may properly come before the stockholders.
 
On the Record Date, the Company had 8,500,000 shares of Common Stock issued and outstanding with the holders thereof being entitled to cast one vote per share.
 
On November 15, 2017, our board of directors unanimously adopted resolutions approving the Redomicile Merger and recommended that our stockholders approve the Redomicile Merger including the Merger Agreement, the Plan of Merger and the Amended and Restated Articles of Association substantially as set forth in Exhibits A and B, respectively.
  
As of the date of this Information Statement, all of the holders of our issued and outstanding Common Stock, the sole class of our voting securities, have consented in writing to the Redomicile Merger .
 
Accordingly, we have obtained all necessary corporate approvals in connection with the Redomicile Merger. This Information Statement is furnished solely for the purposes of advising stockholders of the action taken by written consent and giving stockholders notice of such actions taken as required by the Exchange Act.
 
As the actions taken by the stockholders were by written consent, there will be no stockholders' meeting.
 
We will, when permissible following the expiration of the 20-day period mandated by Rule 14c-2 of the Exchange Act and the provisions of the DGCL, file the Certificate of Merger with the Delaware Secretary of State's Office and the Plan of Merger with the Registrar of Companies of the Cayman Islands , along with other documents required under the Cayman Islands laws. The Redomicile Merger will become effective on the date the Plan of Merger is registered by the Registrar of Companies of the Cayman Islands, which will occur at least 20 days after this Information Statement is first mailed to our stockholders.


1

 
SUMMARY

The following summary highlights selected information from this Information Statement and may not contain all of the information that is important to you. To better understand the Merger Agreement, including the Redomicile Merger and other transactions contemplated thereby, you should carefully read this entire Information Statement, including the Merger Agreement attached as Annex A to this Information Statement and the Plan of Merger attached as Annex A to the Merger Agreement. For purposes of this Information Statement, the term “Merger Agreement” will refer to the Merger Agreement, as the same may be amended.

The Redomicile Merger

The Parties to the Merger Agreement and the Plan of Merger

China Biotech Holdings, Inc.   The Company is currently considered to be a “blank check” company. The SEC defines those companies as “any development stage company that is issuing a penny stock, within the meaning of Section 3(a)(51) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that has no specific business plan or purpose, or has indicated that its business plan is to merge with an unidentified company or companies.” Under SEC Rule 12b-2 under the Exchange Act, the Company also qualifies as a “shell company,” because it has no or nominal assets (other than cash) and no or nominal operations.

We intend to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of having its common stock registered under the Exchange Act. The Company’s principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through a combination with a business rather than immediate, short-term earnings. The Company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. Although management has not restricted the geographical location of the target companies to China, management believes that it is probable that the target’s operations will be based in China or Asia.

Zhong Yuan Bio-Technical Holdings Limited.  Zhong Yuan Bio-Technical Holdings Limited (“Zhong Yuan”) was formed in July 2016 as an exempted company limited by shares under the laws of the Cayman Islands and is currently a wholly-owned subsidiary of the Company. An “exempted” company under the laws of the Cayman Islands is one which receives such registration as a result of satisfying the Registrar of Companies in the Cayman Islands that it conducts its operations mainly outside of the Cayman Islands and is, as a result, exempted from complying with certain provisions of the Companies Law (2016 Revision) of the Cayman Islands, such as the general requirement to file an annual return of its shareholders with the Registrar of Companies, and is permitted flexibility in certain matters, such as the ability to register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands. Zhong Yuan does not have a significant amount of assets or liabilities and has not engaged in any business since its incorporation other than activities associated with its anticipated participation in the Redomicile Merger.
 
The principal executive offices of each of the Company and Zhong Yuan are located at Suite 2432, Sun Hung Kai Centre, 30 Harbour Road, Wanchai, Hong Kong; Telephone: +852 29198916; Facsimile: +852 25747287.
 
 
2


 
Background and Reasons for the Redomicile Merger

We believe that the Redomicile Merger, which would change our place of incorporation from Delaware to the Cayman Islands, (i) would allow us to reduce operational, administrative, legal and accounting costs over the long term because Zhong Yuan is expected to qualify as a foreign private issuer and be exempt from certain rules under the Exchange Act, which is in line with the Company’s expectation that, subsequent to a merger with an operating company, the Company’s business and operations will be conducted primarily outside of the United States, and (ii) will more closely align our structure with our international corporate strategy. Because we anticipate that, subsequent to our merger with an operating company, substantially all of our executive team and members of our board of directors will likely reside outside the United States, we believe that it is advisable to move our place of incorporation outside the United States. In reaching its decision to approve the Merger Agreement, our board of directors identified several potential benefits to our stockholders, which are described under “The Redomicile Merger — Background and Reasons for the Redomicile Merger.”

The Merger Agreement

A copy of the Merger Agreement, including the Plan of Merger, is attached as Annex A to this Information Statement. The Company encourages you to read the entire Merger Agreement and Plan of Merger carefully, as they are the principal documents governing the Redomicile Merger.

Zhong Yuan Ordinary Shares

When the Redomicile Merger is completed, each share of the Company's Common Stock shall convert into the right to receive one ordinary share in the capital of Zhong Yuan, which ordinary shares will be issued by Zhong Yuan in connection with the Redomicile Merger. Following the Redomicile Merger, the former stockholders of the Company will become holders of Zhong Yuan ordinary shares, and Zhong Yuan will own and continue to conduct our business in substantially the same manner as is currently being conducted by the Company. In light of the fact that the Company has only three stockholders, the ordinary shares will be issued to the stockholders of the Company in reliance on exemptions from registration provided by Regulation S with respect to Ms. Ting Ting Chang, and Section 4(a)(2) of the U.S. Securities Act of 1933 (the "Securities Act") with respect to all three shareholders. The share certificates issued by Zhong Yuan will each contain a restrictive legend, and all shares issued will constitute restricted securities.

Treatment of the Company’s Options, Warrants and Convertible Securities

In connection with the Redomicile Merger, each outstanding option, warrant or convertible security exercisable or convertible into Common Stock of the Company will be assumed by Zhong Yuan and will become an option, warrant or convertible security exercisable or convertible into an equal number of ordinary shares in the capital of Zhong Yuan under the same terms and conditions.


3


Overview of the Merger Agreement

The Company and Zhong Yuan are required to complete the Redomicile Merger only if certain customary conditions are satisfied or waived, including the Merger Agreement and the Plan of Merger being approved by the Company’s and Zhong Yuan’s stockholders.

Board of Directors; Management of Zhong Yuan Following the Redomicile Merger

Following the Redomicile Merger, Zhong Yuan will be managed by the same board of directors and executive officers that manage the Company.

Accounting Treatment

The Redomicile Merger will be accounted for as a legal reorganization with no change in ultimate ownership interest immediately before and after the transaction. Accordingly, all assets and liabilities will be recorded at historical cost as an exchange between entities under common control.

Material U.S. Federal Income Tax Consequences

We do not anticipate that Zhong Yuan will be treated as a U.S. corporation for U.S. federal income tax purposes after the Redomicile Merger. In addition, we intend the Redomicile Merger to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”). Assuming the Redomicile Merger qualifies as a reorganization, a U.S. Holder will not recognize any gain or loss for U.S. federal income tax purposes upon receipt of Zhong Yuan ordinary shares in the Redomicile Merger. A U.S. Holder will have an adjusted tax basis in the Zhong Yuan ordinary shares received in the Redomicile Merger equal to the adjusted tax basis of the Company Common Stock surrendered by such U.S. Holder in the Redomicile Merger. The holding period for Zhong Yuan ordinary shares received in the Redomicile Merger will include the holding period for the Company Common Stock surrendered therefor. Please see the section entitled “Taxation - United States Taxation” beginning on page 16.

Comparison of Stockholder/Shareholder Rights

Upon consummation of the Redomicile Merger, the holders of issued and outstanding Common Stock of the Company will be entitled to receive Zhong Yuan ordinary shares. The rights of the holders of the Company’s Common Stock are governed by the Company’s articles of incorporation and bylaws and DGCL, while the rights of holders of Zhong Yuan’s ordinary shares are generally governed by Zhong Yuan’s memorandum and articles of association and the Companies Law (2016 Revision) of the Cayman Islands as well as the common law of the Cayman Islands. There are differences in rights afforded under Delaware law and Cayman Islands law. Please see the section entitled “Comparison of Rights under Delaware and Cayman Islands Laws.”

 
4


 
THE REDOMICILE MERGER

The Merger Agreement and the Plan of Merger

The following includes a brief summary of the material provisions of the Merger Agreement, a copy of which is attached as Annex A and incorporated by reference into this Information Statement. We encourage you to read the Merger Agreement and the Plan of Merger in their entirety for a more complete description of the Redomicile Merger. In the event of any discrepancy between the terms of the Merger Agreement or the Plan of Merger and the following summary, the Merger Agreement and the Plan of Merger will control.

Introduction

The Merger Agreement and the Plan of Merger provide for a Redomicile Merger that will result in each share of Common Stock of the Company being converted into the right to receive one ordinary share in the capital of Zhong Yuan, an exempted company limited by shares which is incorporated under the laws of the Cayman Islands. Under the Merger Agreement, the Company will merge with and into Zhong Yuan, with Zhong Yuan as the surviving company. We anticipate that the Redomicile Merger will become effective in February of 2018. Following the Redomicile Merger, Zhong Yuan will own and continue to conduct our business in substantially the same manner as it is currently being conducted by the Company. Immediately following the Redomicile Merger, you will own an interest in Zhong Yuan, which will be managed by the same board of directors and executive officers that managed the Company immediately prior to the Redomicile Merger. Additionally, the consolidated assets and liabilities of Zhong Yuan will be the same as those of the Company immediately prior to the Redomicile Merger.

The Parties to the Redomicile Merger

China Biotech Holdings Limited.  The Company is currently considered to be a “blank check” company. The SEC defines those companies as “any development stage company that is issuing a penny stock, within the meaning of Section 3(a)(51) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that has no specific business plan or purpose, or has indicated that its business plan is to merge with an unidentified company or companies.” Under SEC Rule 12b-2 under the Exchange Act, the Company also qualifies as a “shell company,” because it has no or nominal assets (other than cash) and no or nominal operations.

We intend to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of having its common stock registered under the Exchange Act. The Company's principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through a combination with a business rather than immediate, short-term earnings. The Company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. Although management has not restricted the geographical location of the target companies to China, management believes that it is probable that the target's operations will be based in China or Asia.
 
Zhong Yuan Bio-Technology Holdings Limited.   Zhong Yuan Bio-Technology Holdings Limited (“Zhong Yuan”) was incorporated in July 2016 as an exempted company limited by shares under the laws of the Cayman Islands, and is currently a wholly-owned subsidiary of the Company. An “exempted” company under the laws of the Cayman Islands is one which receives such registration as a result of satisfying the Registrar of Companies in the Cayman Islands that it conducts its operations mainly outside of the Cayman Islands and is, as a result, exempted from complying with certain provisions of the Companies Law (2016 Revision) of the Cayman Islands, such as the general requirement to file an annual return of its shareholders with the Registrar of Companies, and is permitted flexibility in certain matters, such as the ability to register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands. Zhong Yuan does not have a significant amount of assets or liabilities and has not engaged in any business since its incorporation other than activities associated with its anticipated participation in the Redomicile Merger.

The principal executive offices of each of the Company and Zhong Yuan are located at Suite 2432, Sun Hung Kai Centre, 30 Harbour Road, Wanchai, Hong Kong; Telephone: + 852 29198916; Facsimile: +852 25747287.
 
 
5


 
Background and Reasons for the Redomicile Merger

We believe that the Redomicile Merger, which would change our place of incorporation from Delaware to the Cayman Islands, (i) would allow us to reduce operational, administrative, legal and accounting costs over the long term because Zhong Yuan is expected to qualify as a foreign private issuer and be exempt from certain rules under the Exchange Act, which is in line with the Company’s expectation that, subsequent to a merger with an operating company, the Company’s business and operations will be conducted primarily outside of the United States, and (ii) will more closely align our structure with our international corporate strategy. Because we anticipate that, subsequent to our merger with an operating company, substantially all of our executive team and members of our board of directors will likely reside outside the United States, we believe that it is advisable to move our place of incorporation outside the United States. In reaching its decision to approve the Merger Agreement, our board of directors identified several potential benefits to our stockholders, which are described below.

We believe the Redomicile Merger, which would change our place of incorporation from Delaware to the Cayman Islands, is consistent with our corporate strategy of merging with a company which primarily conducts its operations outside the United States, and would allow us to reduce operational, administrative, legal and accounting costs over the long term.

We have chosen to reorganize under the laws of the Cayman Islands because of its political and economic stability, effective judicial system, absence of exchange control or currency restrictions and availability of professional and support services.

 
We believe that by reincorporating to a jurisdiction outside the United States, which is in line with the Company’s anticipated business and operations which are expected to be primarily conducted outside of the United States, Zhong Yuan will be able to qualify as a “foreign private issuer” under the rules and regulations of the SEC and we expect that the reduced reporting obligations associated with being a foreign private issuer will reduce operational, administrative, legal and accounting costs in the long term. Zhong Yuan will remain subject to the mandates of the Sarbanes-Oxley Act. As a foreign private issuer, Zhong Yuan also will be exempt from certain rules under the Exchange Act that would otherwise apply if Zhong Yuan were a company incorporated in the United States or did not meet the other conditions to qualify as a foreign private issuer. For example: Zhong Yuan may include in its SEC filings financial statements prepared in accordance with U.S. GAAP or with IFRS as issued by the IASB without reconciliation to U.S. GAAP;
 
 
6


 
 
Zhong Yuan will not be required to provide as many Exchange Act reports, or as frequently or as promptly, as U.S. companies with securities registered under the Exchange Act. For example, Zhong Yuan will not be required to file current reports on Form 8-K within four business days from the occurrence of specific material events. Instead, Zhong Yuan will need to promptly furnish reports on Form 6-K regarding any information that Zhong Yuan (a) makes or is required to make public under the laws of the Cayman Islands, (b) files or is required to file under the rules of any stock exchange, or (c) otherwise distributes or is required to distribute to its shareholders. Unlike Form 8-K, there is no precise deadline by which Form 6-K must be furnished. In addition, Zhong Yuan will not be required to file its annual report on Form 10-K, which may be due as soon as 60 days after its fiscal year end. As a foreign private issuer, Zhong Yuan will be required to file an annual report on Form 20-F within four months after its fiscal year end;

 
Zhong Yuan will not be required to provide the same level of disclosure on certain issues, such as executive compensation;

 
Zhong Yuan will not be required to conduct advisory votes on executive compensation;

 
Zhong Yuan will be exempt from filing quarterly reports under the Exchange Act with the SEC;

 
Zhong Yuan will not be subject to the requirement to comply with Regulation FD, which imposes certain restrictions on the selected disclosure of material information;

 
Zhong Yuan will not be required to comply with the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; and

 
Zhong Yuan will not be required to comply with Section 16 of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and establishing insider liability for profits realized from any “short-swing” trading transaction.

Zhong Yuan expects to take advantage of these exemptions after the Redomicile Merger is effected. Accordingly, after the completion of the Redomicile Merger, if you hold Zhong Yuan securities, you may receive less information about Zhong Yuan and its business than you currently receive with respect to the Company and may be afforded less protection under the U.S. federal securities laws than you are entitled to currently.
 
 
7


 
Additionally, as a foreign private issuer, Zhong Yuan will be permitted to follow corporate governance practices in accordance with Cayman Islands laws in lieu of certain exchange corporate governance standards, such as the following NASDAQ corporate governance standards requiring that:

 
the majority of the board of directors be comprised of independent directors;

 
executive compensation be determined by independent directors or a committee of independent directors;

 
director nominees be selected, or recommended for selection, by the board of directors, by independent directors or by a committee of independent directors;

 
an audit committee be comprised of at least three members, each of whom is an independent director and one of whom has finance and accounting experience; and

 
all related party transactions be reviewed by the audit committee or another independent body of the board of directors.

We believe  that there are no comparable Cayman Islands laws related to the above corporate governance standards.

Subsequent to merging with an operating target, it is the intent of Zhong Yuan to list its ordinary shares on the NASDAQ Stock Market or the NYSE American Market as soon as it qualifies to do so under the applicable rules.

We believe the Redomicile Merger will enhance shareholder value for the reasons discussed above. However, in light of the fact that the achievement of our objectives depends on many things, including, among other things, future laws and regulations, as well as the development of our business after effecting a merger with an operating target, we cannot predict what impact, if any, the Redomicile Merger will have in the long term when these factors change.

There are certain disadvantages that accompany redomicile in the Cayman Islands, including:

 
The Cayman Islands has a different body of securities laws and corporate laws as compared to the United States and may provide significantly less protection to investors;

 
Cayman Islands companies may not have standing to sue before the federal courts of the United States; and

 
Zhong Yuan’s constitutional documents do not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between it and our officers, directors and shareholders be arbitrated.
 
 
8


 
Zhong Yuan’s corporate affairs are governed by Zhong Yuan’s memorandum and articles of association, as amended and restated from time to time, the Companies Law and the common law of the Cayman Islands. The rights of shareholders to take action against the directors and officers of Zhong Yuan, actions by minority shareholders and the fiduciary duties of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands, as well as from English common law, which has persuasive, but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary duties of our directors, although clearly established under Cayman Islands law, are not specifically prescribed in statute or a particular document in the same way that they are in certain statutes or judicial precedent in some jurisdictions in the United States.

We anticipate that, subsequent to our merger with an operating company, substantially all of our executive team and members of our board of directors will continue to reside outside the United States and all or a substantial portion of such persons’ assets will be located outside the United States. In addition, we anticipate that all of our operations will be conducted outside the United States and that all of our assets will be located outside the United States. As a result, it may be difficult for you to effect service of process within the United States upon Zhong Yuan or such persons, or to enforce against them in courts of the United States or of the Cayman Islands, judgments obtained in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States.

The Redomicile Merger

The steps that have been taken to date, and that will be taken, to complete the Redomicile Merger are:

 
Zhong Yuan was incorporated with the Company holding 100 percent of the ordinary shares issued by Zhong Yuan, consisting of 100 shares.

 
Upon effectiveness of the Redomicile Merger (the “Effective Time”) (i) the Company will merge with and into Zhong Yuan, with Zhong Yuan as the surviving company, and (ii) each share of the Company’s Common Stock will be converted into the right to receive one ordinary share in the capital of Zhong Yuan and Zhong Yuan shall issue to each holder of such right that number of ordinary shares in Zhong Yuan to which each such holder is entitled.

 
At the Effective Time, Zhong Yuan will cancel the 100 ordinary shares issued to the Company prior to the Redomicile Merger and all Common Stock of the Company will be cancelled.

At the Effective Time, any existing equity compensation plans of the Company, as may be amended, will be adopted and assumed by Zhong Yuan. Each outstanding option and other equity award issued under our equity compensation plans for the purchase or receipt of, or payment based on, each share of the Company’s Common Stock will represent the right to purchase or receive, or receive payment based on, one ordinary share in the capital of Zhong Yuan on substantially the same terms.

Additionally, at the Effective Time, Zhong Yuan will adopt and assume the obligations of the Company under or with respect to any contracts or agreements as described in the Merger Agreement. The contracts and agreements will become the obligations of Zhong Yuan and will be performed in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated.

The Merger Agreement and the Plan of Merger may be amended, modified or supplemented at any time. However, no amendment, modification or supplement that requires approval by the Company’s stockholders may be made or effected without obtaining that approval.
 
 
9


 
Possible Abandonment

Pursuant to the Merger Agreement, the board of directors of the Company may exercise its discretion to terminate the Merger Agreement, and therefore abandon the Redomicile Merger, at any time prior to the Effective Time, including after the adoption of the Merger Agreement by the Company’s stockholders.

Additional Agreements

Zhong Yuan expects to enter into indemnification agreements in the future with its officers and directors that are consistent with the laws of the Cayman Islands. Generally, we anticipate that the indemnification agreements will require that Zhong Yuan indemnify and hold an indemnitee harmless to the fullest extent permitted by law for liabilities arising out of the indemnitee’s current or past association with Zhong Yuan, any subsidiary of Zhong Yuan or another entity where he or she is or was serving at Zhong Yuan’s request as a director or officer or in a similar capacity that involves services with respect to any employee benefit plan.

The indemnification agreements also are expected to provide for the advancement of defense expenses by Zhong Yuan. Please also see the section entitled “Comparison of Rights under Delaware and Cayman Islands Laws — Indemnification of Directors and Officers” for a description of indemnification of directors and officers under Cayman Islands law and Zhong Yuan’s memorandum and articles of association.

Conditions to Completion of the Redomicile Merger

The following conditions must be satisfied or waived, if allowed by law, to complete the Redomicile Merger:

 
the Merger Agreement and the Plan of Merger have been approved and adopted by the requisite vote of stockholders of the Company and of Zhong Yuan;

 
none of the parties to the Merger Agreement is subject to any decree, order or injunction that prohibits the consummation of the Redomicile Merger;

 
all material consents and authorizations of, filings or registrations with, and notices to, any governmental or regulatory authority required of the Company, Zhong Yuan or their subsidiaries to consummate the Redomicile Merger have been obtained or made; and

 
the representations and warranties of the parties to the Merger Agreement set forth in the Merger Agreement are true and correct in all material respects, and the covenants of the parties set forth in the Merger Agreement (other than those to be performed after the Effective Time) have been performed in all material respects.
 
 
10


 
Our board of directors currently does not anticipate any circumstances in which it would waive the conditions listed above; however, in the event it determines that a waiver of any such conditions is in the best interests of the Company and our stockholders and that such change to the terms of the Redomicile Merger does not make the disclosure provided to our stockholders materially misleading (for example, if a representation in the Merger Agreement is not true but there is otherwise no harm to the Company or our stockholders), our board of directors will not resolicit stockholder approval of the Redomicile Merger. If a waiver of any condition listed above would make the disclosure provided to our stockholders materially misleading, our board of directors will resolicit shareholder approval of the Redomicile Merger. Additionally, our board of directors reserves the right to defer or abandon the Redomicile Merger.

Stock Compensation and Benefit Plans and Programs

As part of the Redomicile Merger, Zhong Yuan has agreed to assume all of the Company’s rights and obligations under any stock-based benefit and compensation plans and programs of the Company at the Effective Time. All rights to purchase or receive, or receive payment based on, each share of the Company’s Common Stock arising under our equity compensation plans will entitle the holder to purchase or receive, or receive payment based on, as applicable, one Zhong Yuan ordinary share. At present, neither the Company nor Zhong Yuan has any stock-based compensation plans or programs. Such plans or programs may be adopted in the future.

Warrants, Convertible Debentures or Convertible Securities

In addition, as part of the Redomicile Merger, Zhong Yuan has agreed to assume all of the Company’s rights and obligations of any warrants, convertible debentures or other convertible securities that may convert into the Company’s Common Stock at the Effective Time. All rights to purchase or receive, or receive payment based on, each share of the Company’s Common Stock arising under our warrants, convertible debentures or other convertible securities will entitle the holder thereof to purchase or receive, or receive payment based on, as applicable, one Zhong Yuan ordinary share. At present, neither the Company nor Zhong Yuan has any warrants, debentures or convertible securities.

Effective Time

We anticipate that the Redomicile Merger will become effective in February 2018. Our board of directors will have the right, however, to defer or abandon the Redomicile Merger at any time if it concludes that completion of the Redomicile Merger would not be in the best interests of the Company or our stockholders.
 
 
11


 
Management of Zhong Yuan

Immediately prior to the Effective Time, the directors and officers of the Company at such time will be elected or appointed as the directors and officers of Zhong Yuan (to the extent the directors and officers of Zhong Yuan and the Company are not already identical), each such person to have the same office(s) with Zhong Yuan (and the same class designations and committee memberships in the case of directors) as he or she held with the Company, with the directors to serve until the earlier of the next meeting of Zhong Yuan’s shareholders at which an election of directors of their respective classes is required or until their successors are elected or appointed (or their earlier death, disability or retirement).

Regulatory Approvals

The only governmental or regulatory approvals or actions that are required to complete the Redomicile Merger are compliance with U.S. federal and state securities laws and Delaware corporate law (including the filing with the Secretary of State of the State of Delaware of a certificate of merger).

Rights of Dissenting Stockholders

Under the DGCL, the Company's shareholders will have appraisal rights in connection with the Redomicile Merger, unless they have voted in favor of the Redomicile Merger or consented to the Redomicile Merger in writing. The Company will notify any shareholder who is entitled to appraisal rights of the approval of the Redomicile Merger and that appraisal rights are available, and will furnish such shareholder with a copy of the relevant section of the Delaware General Corporation Law which sets forth the procedure for demanding an appraisal of the shareholder's shares. Since all of the Company's shareholders have consented in writing to the Redomicile Merger, none of the Company's shareholders have appraisal rights under the DGCL.

Ownership in Zhong Yuan

Each share of the Company’s Common Stock registered in your name or which you beneficially own through your broker will be converted into the right to receive one ordinary share in the capital of Zhong Yuan and such ordinary share will be registered in your name (or your broker’s name, as applicable) in Zhong Yuan’s register of members upon completion of the Redomicile Merger, without any further action on your part. Upon completion of the Redomicile Merger, only registered shareholders reflected in Zhong Yuan’s register of members will have and be entitled to exercise any voting and other rights with respect to and to receive any dividend and other distributions upon Zhong Yuan ordinary shares registered in their respective names. Any attempted transfer of the Company’s stock prior to the Redomicile Merger that is not properly documented and reflected in the stock records maintained by the Company as of immediately prior to the Effective Time will not be reflected in Zhong Yuan’s register of members upon completion of the Redomicile Merger.

If you hold the Company’s Common Stock in an account with a broker or other securities intermediary, you will receive delivery of ordinary shares in your account with that same broker or securities intermediary without any action on your part. If you hold the Company’s Common Stock in certificated form, you may exchange your stock certificates for new Zhong Yuan share certificates following the Redomicile Merger. We will request that all Company stock certificates be returned to the Company following the Redomicile Merger. Soon after the closing of the Redomicile Merger, you will be sent a letter of transmittal from us. The letter of transmittal will contain instructions explaining the procedure for surrendering your stock certificates of the Company for new Zhong Yuan share certificates.

Stock Exchange Listing

There is currently no established public trading market for the Company’s Common Stock or for Zhong Yuan’s ordinary shares.
 
12


 
Accounting Treatment of the Redomicile Merger

The Redomicile Merger will be accounted for as a legal reorganization with no change in ultimate ownership interest immediately before and after the transaction. Accordingly, no business combination has occurred and all assets and liabilities will be recorded at historical cost as an exchange between entities under common control.

Taxation

The following discussion of the material Cayman Islands and U.S. federal income tax consequences of the Redomicile Merger is based upon laws and relevant interpretations thereof effective as of the date of this Information Statement, all of which are subject to change, possibly with retroactive effect. This discussion does not deal with all possible tax consequences relating to the Redomicile Merger or otherwise, such as the tax consequences under laws of countries other than the Cayman Islands and the United States or under state and local tax laws.

Cayman Islands Taxation

The Cayman Islands government (or any other taxing authority in the Cayman Islands) currently does not levy taxes on individuals or corporations based upon profits, income, gains or appreciation, and there is no taxation in the Cayman Islands in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to Zhong Yuan levied by the government of the Cayman Islands except for stamp duty, which may be applicable on instruments executed in, or brought within the jurisdiction of the Cayman Islands. No stamp duties or other similar taxes or charges are payable under the laws of the Cayman Islands in respect of the execution or delivery of any of the documents relating the proposed Redomicile Merger or the performance or enforcement of any of them, unless they are executed in or thereafter brought within the jurisdiction of the Cayman Islands for enforcement purposes or otherwise. We do not intend that any documents relating the proposed Redomicile Merger be executed in or brought within the jurisdiction of the Cayman Islands. There are no exchange control regulations or currency restrictions in the Cayman Islands.
 
13


 
United States Taxation

The following are the material U.S. federal income tax consequences of the Redomicile Merger to beneficial owners of Company Common Stock. This discussion is based on the Code, applicable Treasury regulations, administrative interpretations and court decisions as in effect as of the date of this Information Statement, all of which may change, possibly with retroactive effect.

This discussion addresses only the consequences of the exchange of shares of Company Common Stock held as capital assets. It does not address all aspects of U.S. federal income taxation that may be important to a beneficial owner in light of his or her particular circumstances, including alternative minimum tax and Medicare contribution tax consequences, or tax consequences that may apply to a beneficial owner subject to special rules, such as:

 
a financial institution or insurance company;

 
a tax-exempt organization;

 
a dealer or broker in securities, commodities or foreign currencies;

 
a shareholder that holds Company Common Stock as part of a hedge, appreciated financial position, straddle, conversion or other risk reduction transaction;

 
a U.S. Holder (as defined below) whose functional currency is not the U.S. dollar;

 
a shareholder that beneficially owns five percent or more of Company Common Stock;

 
a shareholder that acquired Company Common Stock pursuant to the exercise of compensatory options or otherwise as compensation.

This discussion of material U.S. federal income tax consequences is not a complete analysis or description of all potential U.S. federal income tax consequences of the Redomicile Merger. This discussion does not address tax consequences that may vary with, or are contingent on, individual circumstances. In addition, it does not address any non-income tax or any non-U.S., state or local tax consequences. Accordingly, each Company shareholder should consult its own tax advisor to determine the particular U.S. federal, state or local or non-U.S. income or other tax consequences to it of the Redomicile Merger.

U.S. Federal Income Tax Consequences of the Redomicile Merger to the Company and Zhong Yuan

Neither the Company nor Zhong Yuan will recognize any gain or loss for U.S. federal income tax purposes as a result of the Redomicile Merger.

Pursuant to Section 7874 of the Code, Zhong Yuan will not be treated as a U.S. corporation under the Code because (i) after the Redomicile Merger, Zhong Yuan will have acquired substantially all of the properties held directly or indirectly by the Company, (ii) after the Redomicile Merger, Zhong Yuan will not have substantial business activities in the Cayman Islands, and (iii) the former holders of the Company’s Common Stock will hold, by reason of owning shares of the Company’s Common Stock, at least 80% or more of the Zhong Yuan ordinary shares.
 
 
14


 
U.S. Federal Income Tax Consequences of the Redomicile Merger to U.S. Holders

This section applies to beneficial owners of Company Common Stock that are U.S. Holders. A U.S. Holder is a beneficial owner of Company Common Stock that is for U.S. federal income tax purposes:

 
a citizen or individual resident of the United States;

 
a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; or

 
an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.

A U.S. Holder will not recognize any gain or loss for U.S. federal income tax purposes upon receipt of Zhong Yuan ordinary shares in the Redomicile Merger. A U.S. Holder will have an adjusted tax basis in the Zhong Yuan ordinary shares received in the Redomicile Merger equal to the adjusted tax basis of the Company Common Stock surrendered by such U.S. Holder in the Redomicile Merger. The holding period for Zhong Yuan ordinary shares received in the Redomicile Merger will include the holding period for the Company Common Stock surrendered therefor.

The U.S. federal income tax consequences of owning and disposing of Zhong Yuan ordinary shares received in the Redomicile Merger will be the same as the U.S. federal income tax consequences of owning and disposing of Company Common Stock before the Redomicile Merger. Each U.S. Holder should consult its own tax advisor to determine the particular U.S. federal, state or local or non-U.S. income or other tax consequences to it of the ownership and disposition of Zhong Yuan ordinary shares.
 
15

 
U.S. Federal Income Tax Consequences of the Redomicile Merger to Non-U.S. Holders

This section applies to beneficial owners of Company Common Stock that are Non-U.S. Holders. A Non-U.S. Holder is a beneficial owner of Company Common Stock that is for U.S. federal income tax purposes:

 
a nonresident alien individual;

 
a non-U.S. corporation; or

 
a non-U.S. estate or trust.

A beneficial owner is not a Non-U.S. Holder if the beneficial owner is a nonresident alien individual present in the United States for 183 days or more in the taxable year of disposition, or if the beneficial owner is a former citizen or former resident of the United States, in either of which cases the beneficial owner should consult his or her tax advisor regarding the U.S. federal income tax consequences of the Redomicile Merger and of owning or disposing of Zhong Yuan ordinary shares.

The receipt of Zhong Yuan ordinary shares in exchange for Company Common Stock will not be a taxable transaction to Non-U.S. Holders for U.S. federal income tax purposes.

The U.S. federal income tax consequences of owning and disposing of Zhong Yuan ordinary shares received in the Redomicile Merger will be the same as the U.S. federal income tax consequences of owning and disposing of Company Common Stock before the Redomicile Merger, including that dividends paid by Zhong Yuan to Non-U.S. Holders will generally be subject to U.S. federal withholding tax at a 30% rate (or a reduced rate specified by an applicable income tax treaty). Each Non-U.S. Holder should consult its own tax advisor to determine the particular U.S. federal, state or local or non-U.S. income or other tax consequences to it of the ownership and disposition of Zhong Yuan ordinary shares.

DESCRIPTION OF SHARE CAPITAL OF ZHONG YUAN

The following description of the material terms of Zhong Yuan’s ordinary shares following the Redomicile Merger includes a summary of specified provisions of the amended and restated memorandum of association and articles of association of Zhong Yuan that will be in effect upon completion of the Redomicile Merger. This description is qualified by reference to the amended and restated memorandum of association and articles of association of Zhong Yuan that will become effective upon consummation of the Redomicile Merger, which are attached as Annex B to this Information Statement and incorporated herein by reference. You are encouraged to read the relevant provisions of the Companies Law and Zhong Yuan’s amended and restated memorandum and articles of association as they relate to the following summary.



16


Authorized Share Capital

Zhong Yuan is authorized to issue 500,000,000 shares of a par value of US$0.0001 each. The board of directors of Zhong Yuan is authorized to issue these shares in different classes and series and, with respect to each class or series, to determine the designations, powers, preferences, privileges and other rights, including dividend rights, conversion rights, terms of redemption and liquidation preferences, any or all of which may be greater than the powers and rights associated with the ordinary shares, at such times and on such other terms as they think proper.

As of the close of business on November 15, 2017, Zhong Yuan had 100 ordinary shares issued and outstanding and no preference shares issued and outstanding. Upon the completion of the Redomicile Merger, Zhong Yuan will issue approximately 8,500,000 ordinary shares in the Redomicile Merger and the 100 ordinary shares issued and outstanding prior to the Redomicile Merger will be cancelled.

Ordinary Shares

General

All of Zhong Yuan's issued and outstanding ordinary shares will be issued credited as fully paid and non-assessable. Zhong Yuan's ordinary shares are issued in registered form, and are issued when registered in Zhong Yuan's register of members. Zhong Yuan's shareholders who are non-residents of the Cayman Islands may freely hold and transfer their ordinary shares, other than as restricted by United States securities laws.

Dividends

The holders of Zhong Yuan’s ordinary shares are entitled to such dividends as may be declared by Zhong Yuan’s board of directors, subject to the Companies Law and the memorandum and articles of association of Zhong Yuan, as amended and restated from time to time. Under Cayman Islands law, dividends may be declared and paid only out of funds legally available therefor, namely out of either profit or share premium account, provided that in no circumstances may Zhong Yuan pay a dividend if this would result in Zhong Yuan being unable to pay its debts as they fall due in the ordinary course of business.

Register of Members

Under Cayman Islands law, Zhong Yuan must keep a register of members and there shall be entered therein:

 
the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member;

 
the date on which the name of any person was entered on the register as a member; and

 
the date on which any person ceased to be a member.

Under Cayman Islands law, the register of members of Zhong Yuan is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of members shall be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. Upon the closing of the Redomicile Merger, the register of members shall be immediately updated to reflect the issue of ordinary shares by Zhong Yuan to the Company’s stockholders. Once Zhong Yuan’s register of members has been updated, the shareholders recorded in the register of members will be deemed to have legal title to the ordinary shares set against their name in the register of members.
 
 
17


 
Voting Rights

Each holder of ordinary shares is entitled to one vote on all matters upon which the ordinary shares are entitled to vote on a show of hands or, on a poll, each holder is entitled to have one vote for each share registered in his name on the register of members. Voting at any meeting of shareholders is by show of hands unless a poll is demanded. A poll may be demanded by the chairman of Zhong Yuan’s board of directors or by any one or more shareholders holding at least one-tenth of the votes attaching to the issued and outstanding ordinary shares in Zhong Yuan entitled to vote at general meetings, present in person or by proxy.

A quorum required for a general meeting of shareholders consists of one or more shareholders who hold in aggregate at least one-third of the votes attaching to the issued and outstanding ordinary shares in Zhong Yuan entitled to vote at general meetings, present in person or by proxy or, if a corporation or other non-natural person, by its duly authorized representative. Although not required by the Companies Laws or Zhong Yuan’s amended and restated memorandum and articles of association, Zhong Yuan expects to hold shareholders’ meetings annually and such meetings may be convened by Zhong Yuan’s board of directors on its own initiative or upon a request to the directors by shareholders holding in aggregate at least 25% in par value of Zhong Yuan’s issued shares that carry the right to vote at general meetings. An extraordinary general meeting may also be called by the Chairman of the Board or the President of Zhong Yuan. Advance notice of at least 10 days is required for the convening of Zhong Yuan’s annual general meeting and other shareholders meetings.

An ordinary resolution to be passed by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy in a general meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy in a general meeting. An ordinary resolution may also be passed by a written resolution signed by a simple majority of all votes entitled to be cast, whereas a special resolution requires a written resolution signed by all the shareholders of Zhong Yuan, as required by the Companies Law and the amended and restated memorandum and articles of association of Zhong Yuan. A special resolution will be required for important matters such as change of name or making changes to the memorandum and articles of association of Zhong Yuan.

Transfer of Ordinary Shares

The ordinary shares to be issued to the current shareholders of the Company will be issued pursuant to exemptions from the registration provisions of Securities Act and therefore will be subject to restrictions on transfer pursuant to the Securities Act.  The certificates representing those ordinary shares will contain an appropriate restrictive legend, and stop transfer instructions will be entered in the share records of Zhong Yuan relative to those shares.

Subject to the above restrictions and any restrictions contained in Zhong Yuan's articles of association, as applicable, any of Zhong Yuan's shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by Zhong Yuan's board.
 
18


 
Zhong Yuan’s board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which Zhong Yuan has a lien. Zhong Yuan’s directors may also decline to register any transfer of any ordinary share unless:

 
the instrument of transfer is lodged with Zhong Yuan, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as Zhong Yuan’s board of directors may reasonably require to show the right of the transferor to make the transfer;

 
the instrument of transfer is in respect of only one class of ordinary shares;

 
the instrument of transfer is properly stamped, if required;

 
in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; or

 
the ordinary shares transferred are free of any lien in favor of Zhong Yuan.

If Zhong Yuan’s directors refuse to register a transfer they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. The registration of transfers may, on 14 days’ notice being given by advertisement in one or more newspapers or by electronic means, be suspended and the register closed at such times and for such periods as Zhong Yuan’s board of directors may from time to time determine; provided, however, that the registration of transfers shall not be suspended and the register shall not be closed for more than 30 days in any year.

Liquidation

On a winding up of Zhong Yuan, if the assets available for distribution among its shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus will be distributed among its shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to Zhong Yuan for unpaid calls or otherwise. If Zhong Yuan’s assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by its shareholders in proportion to the par value of the shares held by them.

Calls on Ordinary Shares and Forfeiture of Ordinary Shares

Zhong Yuan’s board of directors may from time to time make calls upon shareholders for any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 days prior to the specified time of payment. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.
 
 
19


 
Redemption, Repurchase and Surrender of Ordinary Shares

Zhong Yuan may issue shares on terms that are subject to redemption, at Zhong Yuan’s option or at the option of the holders, on such terms and in such manner as may be determined before the issue of such shares, by Zhong Yuan’s board of directors or by a special resolution of Zhong Yuan’s shareholders. Zhong Yuan may also repurchase any of its shares provided that the manner and terms of such purchase have been agreed between the board of directors and the relevant shareholder or are otherwise authorized by its memorandum and articles of association.

Under the Companies Law, the redemption or repurchase of any share may be paid out of Zhong Yuan’s profits or out of the proceeds of a fresh issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if Zhong Yuan can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Law no such share may be redeemed or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares outstanding, or (c) if the company has commenced liquidation. In addition, Zhong Yuan may accept the surrender of any fully paid share for no consideration.

Variations of Rights of Shares

All or any of the special rights attached to any class of shares may, subject to the provisions of the Companies Law, be varied either with the written consent of the holders of not less than two-thirds of the issued shares of that class or with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class.

Inspection of Books and Records

Holders of Zhong Yuan’s ordinary shares have no general right under Cayman Islands law to inspect or obtain copies of Zhong Yuan’s list of shareholders or its corporate records. However, Zhong Yuan will file Annual Reports on Form 20-F, including audited financial statements. See “Additional Information.”

Changes in Capital

Zhong Yuan may from time to time by ordinary resolution:

 
increase its share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe;

 
consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;

 
convert all or any of its paid up shares into stock and reconvert that stock into paid up shares of any denomination;

 
sub-divide its existing shares, or any of them into shares of a smaller amount that is fixed by the amended and restated memorandum and articles of association; and

 
cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled.
 
 
20


 
Subject to the Companies Law and confirmation by the Grand Court of the Cayman Islands on an application by Zhong Yuan for an order confirming such reduction, Zhong Yuan may by special resolution reduce its share capital and any capital redemption reserve in any manner authorized by law.

Issuance of Additional Shares

Zhong Yuan’s amended memorandum and articles of association authorizes Zhong Yuan’s board of directors to issue additional ordinary shares from time to time as its board of directors shall determine, to the extent of available authorized but unissued shares.

Zhong Yuan’s amended memorandum and articles of association authorizes Zhong Yuan’s board of directors to establish from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including:

 
the designation of the series;

 
the number of shares of the series;

 
the dividend rights, dividend rates, conversion rights, voting rights; and

 
the rights and terms of redemption and liquidation preferences.

Zhong Yuan’s board of directors may issue preferred shares without action by its shareholders to the extent authorized but unissued. In addition, the issuance of preferred shares may be used as an anti-takeover device without further action on the part of the shareholders. Issuance of these shares may dilute the voting power of holders of ordinary shares.
 
Exempted Company

Zhong Yuan is an exempted company duly incorporated with limited liability under the Companies Law. The Companies Law distinguishes between ordinary resident companies and exempted companies. Any company, the objects of which are to conduct business mainly outside of the Cayman Islands, may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except for certain exemptions and privileges, including (a) an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies, (b) an exempted company is not required to open its register of members for inspection, (c) an exempted company does not have to hold an annual general meeting, (d) an exempted company may issue no par value, negotiable or bearer shares, (e) an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands, (f) an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance), (g) an exempted company may register as a limited duration company and (h) an exempted company may register as a segregated portfolio company.
 
 
21


 
 “Limited liability” means that the liability of each shareholder is limited to the amount unpaid by the shareholder on that shareholder’s shares of the company (except in exceptional circumstances, such as fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

Transfer Agent

Zhong Yuan will serve as its own transfer agent and registrar for its ordinary shares unless and at least until it completes a merger or acquisition of an operating company.
COMPARISON OF RIGHTS UNDER DELAWARE
AND CAYMAN ISLANDS LAWS

Your rights as a stockholder of the Company are governed by the DGCL and the Company’s articles of incorporation and bylaws. After the Redomicile Merger, you will become a shareholder of Zhong Yuan and your rights will be governed by the Companies Law and Zhong Yuan’s memorandum of association and articles of association.

The principal attributes of the Company’s Common Stock and Zhong Yuan ordinary shares are similar. However, there are differences between your rights under the DGCL and under the Companies Law. In addition, there are differences between the Company’s articles of incorporation and bylaws and Zhong Yuan’s memorandum of association and articles of association. The following discussion is a summary of certain material differences in your rights that will result from the Redomicile Merger. As such, this summary does not cover all the differences between the Companies Law and the DGCL affecting corporations and their shareholders or all of the differences between the Company’s articles of incorporation and bylaws and Zhong Yuan’s memorandum of association and articles of association. While we believe this summary is accurate in all material respects, the following descriptions are qualified in their entirety by reference to the complete text of the relevant provisions of the Companies Law, the DGCL, the Company’s articles of incorporation and bylaws and Zhong Yuan’s memorandum of association and articles of association. Zhong Yuan plans to adopt an amended memorandum and articles of association, which will become effective immediately upon the completion of the Redomicile Merger and will replace its existing memorandum and articles of association in their entirety. A copy of Zhong Yuan’s amended memorandum of association and articles of association that will become effective upon consummation of the Redomicile Merger is attached hereto as Annex C to this Information Statement. We encourage you to read the laws and documents referenced above.

 
 
DGCL/The Company’s Certificate of Incorporation and Bylaws
 
Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Stockholder/Shareholder Approval of Business Combinations; Fundamental Changes
 
Under the DGCL, a merger, consolidation, sale, lease, exchange or other disposition of all or substantially all of the property of a corporation not in the usual and regular course of the corporation’s business, or a dissolution of the corporation, is generally required to be approved by the holders of a majority of the shares outstanding and entitled to vote on the matter, unless the articles of incorporation provides otherwise. The Company’s certificate of incorporation does not provide otherwise.
 
There are a number of mechanisms for acquiring a Cayman Islands company including: (1) a court-approved “scheme of arrangement” under the Companies Law; (2) through a tender offer by a third party; and (3) through a merger or consolidation between the Cayman Islands company and another company incorporated in the Cayman Islands or another jurisdiction (provided that the merger or consolidation is allowed by the laws of that other jurisdiction).
 
 
22


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
 
Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
 
 
In general, under the DGCL, mergers in which the surviving corporation will issue less than 20% of such corporation’s stock does not require shareholder approval. In addition, mergers in which one corporation owns 90% or more of each class of stock of a second corporation may be completed without the vote of the second corporation’s board of directors or shareholders. In certain situations, the approval of a business combination may require approval by a certain number of the holders of a class or series of shares.
 
A scheme of arrangement with one or more class or series of shareholders requires the sanction of the scheme of arrangement by the Cayman Islands court and the approval of a majority in number of the registered holders of each participating class or series of shares voting on the scheme of arrangement, representing 75% or more in value of the shares of each participating class or series voted on such proposal at the relevant meeting excluding any shares held by the acquiring party. If a scheme of arrangement receives the approval of shareholders of a company and is subsequently sanctioned by the Cayman Islands court, all holders of ordinary shares of the company will be bound by the terms of the scheme of arrangement.
         
 
 
The DGCL does not contain a procedure comparable to a scheme of arrangement under the Companies Law.
 
The Companies Law provides that when an offer is made for shares of any class or series of a Cayman Islands company and, within four months of the offer, the holders of not less than 90% of such class or series accept the offer, the offeror may, for two months after that four-month period, require the remaining shareholders of the relevant class or series to transfer their shares on the same terms as the original offer. In those circumstances, non-tendering shareholders will be compelled to sell their shares, unless within one month from the date on which the notice to compulsorily acquire was given to the non-tendering shareholder, the non-tendering shareholder is able to convince a Cayman Islands court to order otherwise.
         
 
 
  
 
Authorization of a merger or consolidation requires: (a) the passing of a special resolution by the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in each such company’s constitutive documents. In addition, the consent of each holder of a fixed or floating security of a constituent company must be obtained, unless the court waives such requirement.
         
 
 
  
 
Under Zhong Yuan’s articles of association and the Companies Law, there is no requirement for shareholder approval for a sale of all or substantially all of Zhong Yuan’s assets.
 
 
 
23


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
 
Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Special Vote Required for Combinations with Interested Stockholders/Shareholders
 
Section 203 of the DGCL provides (in general) that a corporation may not engage in a business combination with an interested stockholder for a period of three years after the time of the transaction in which the person became an interested stockholder.
 
There is no provision in the Companies Law or Zhong Yuan’s articles of association prohibiting business combinations with interested shareholders.
       
 
The prohibition on business combinations with interested stockholders does not apply in some cases, including if: (1) the board of directors of the corporation, prior to the time of the transaction in which the person became an interested stockholder, approves (a) the business combination or (b) the transaction in which the stockholder becomes an interested stockholder; (2) upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced; or (3) the board of directors and the holders of at least two-thirds of the outstanding voting stock not owned by the interested stockholder approve the business combination on or after the time of the transaction in which the person became an interested stockholder.
 
  
       
 
For the purpose of Section 203, the DGCL generally defines an interested stockholder to include any person who, together with that person’s affiliates or associates, (1) owns 15% or more of the outstanding voting stock of the corporation, or (2) is an affiliate or associate of the corporation and owned 15% or more of the outstanding voting stock of the corporation at any time within the previous three years.
 
 
 
 
 
24


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
 
Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Dissenter Rights; Rights to Dissent; Compulsory Acquisition
 
Under the DGCL, a stockholder of a corporation does not have appraisal rights in connection with a merger or consolidation, if, among other things: (1) the corporation’s shares are listed on a national securities exchange or held of record by more than 2,000 stockholders; or (2) the corporation will be the surviving corporation of the merger and no vote of its stockholders is required to approve the merger.
 
The Companies Law and Zhong Yuan’s articles of association do not specifically provide for appraisal rights. However, in connection with the compulsory transfer of shares to a 90% shareholder of a Cayman Islands company as described under “Shareholder Approval of Business Combinations; Fundamental Changes,” a minority shareholder may apply to the Cayman Islands court within one month of receiving notice of the compulsory transfer objecting to that transfer. In these circumstances, the burden is on the minority shareholder to show that the court should exercise its discretion to prevent the compulsory transfer. The court is unlikely to grant any relief in the absence of bad faith, fraud, unequal treatment of shareholders or collusion as between the offeror and the holders of the shares who have accepted the offer as a means of unfairly forcing out minority shareholders.
       
 
However, a stockholder is entitled to appraisal rights in the case of a merger or consolidation effected under certain provisions of the DGCL if the stockholder is required to accept in exchange for the shares anything other than: (1) shares of stock of the corporation surviving or resulting from the merger or consolidation; (2) shares of any other corporation that on the effective date of the merger or consolidation will be either listed on a national securities exchange or held of record by more than 2,000 stockholders; or (3) cash instead of fractional shares of the corporation.
 
In connection with a merger or a consolidation, dissenting shareholders have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) if they follow the required procedures set out in the Companies Law, subject to certain exceptions.
       
 
The Company’s shares are not currently listed on an exchange, they are not held by more than 2,000 shareholders and the Company is not the surviving company in the Merger.
 
  
         
Stockholder/Shareholder Consent to Action Without Meeting
 
Under the DGCL, unless otherwise provided in the certificate of incorporation, any action that can be taken at a meeting of the stockholders may be taken without a meeting if written consent to the action is signed by the holders of outstanding stock having the minimum number of votes necessary to authorize or take the action at a meeting of the stockholders. The Company’s bylaws allow its stockholders to act by written consent.
 
Zhong Yuan’s articles of association permits resolutions to be effected by a written resolution signed by a majority of the shareholders entitled to vote on the resolution and permits special resolutions to be effected by a unanimous written resolution. A special resolution is a resolution that is required to be either (a) passed by a majority of not less than two-thirds of shareholders as, being entitled to do so, vote in person or by proxy at a general meeting, or (b) signed by all the shareholders entitled to vote on that resolution.
 
 
 
25


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
  Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Distributions and Dividends; Repurchases and Redemptions
 
Under the DGCL, a corporation may pay dividends out of capital surplus and, if there is no surplus, out of net profits for the current and/or the preceding fiscal year, unless the net assets of the corporation are less than the capital represented by issued and outstanding shares having a preference on asset distributions. Surplus is defined in the DGCL as the excess of the net assets over capital, as such capital may be adjusted by the board.
 
Under the Companies Law, the board of directors may declare the payment of dividends to holders of ordinary shares out of Zhong Yuan’s (1) profits available for distribution, or (2) “share premium account”, which represents the excess of the price paid to Zhong Yuan on the issue of its shares over the par or “nominal” value of those shares and is similar to the U.S. law concept of additional paid in capital.
       
 
A Delaware corporation may purchase or redeem shares of any class except when its capital is impaired or would be impaired by the purchase or redemption. A corporation may, however, purchase or redeem out of capital shares that are entitled upon any distribution of its assets to a preference over another class or series of its shares, or if no shares entitled to such preference are outstanding, any of its own shares, if such shares will be retired upon their acquisition and the capital of the corporation reduced.
 
However, no dividends may be paid if, after payment, Zhong Yuan would not be able to pay its debts as they come due in the ordinary course of business.
         
  
 
  
 
Dividends on ordinary shares, if any, are at the discretion of the directors and depend on, among other things, Zhong Yuan’s results of operations, cash requirements and surplus, financial condition, contractual restrictions and other factors that the directors deems relevant, as well as Zhong Yuan’s ability to pay dividends in compliance with the Cayman Islands law. Under the Cayman Islands law, Zhong Yuan is not required to present proposed dividends or distributions to its shareholders for approval or adoption. Zhong Yuan may pay dividends in any currency.
         
  
 
  
 
The directors are also entitled to issue shares with preferred rights to participate in dividends declared by Zhong Yuan. The holders of such preference shares may, depending on their terms, rank senior to the ordinary shares with respect to dividends.
         
  
 
  
 
Under the Companies Law, shares of a Cayman Islands company may be redeemed or repurchased out of profits of the company, out of the proceeds of a fresh issue of shares made for that purpose or out of capital, provided the company’s articles authorize this and it has the ability to pay its debts as they come due in the ordinary course of business.
 
 
 
26


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
  Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
  
 
  
 
Zhong Yuan’s articles of association provide that the company may make a payment in respect of the redemption or purchase of its own shares otherwise than out of profits or the proceeds of a fresh issue of shares.
         
Removal of Directors; Terms of Directors
 
Under the DGCL, except in the case of a corporation with a classified board or with cumulative voting, any director or the entire board may be removed, with or without cause, by the holders of a majority of the shares entitled to vote at an election of directors.
 
Under Zhong Yuan’s articles of association, the directors of Zhong Yuan hold office until the expiration of their term or such time as they are removed from office by ordinary resolution of the shareholders.
       
 
The Company’s certificate of incorporation does not provide for either a classified board of directors or for cumulative voting.
 
In addition, the office of any director shall be vacated if the director (i) becomes bankrupt or makes any arrangement or composition with his creditors, (ii) dies or is found to be or becomes of unsound mind, or (iii) resigns his office by notice in writing to Zhong Yuan.
         
  
 
  
 
Directors may be elected by a resolution of the board of directors, or by an ordinary resolution of the shareholders.
         
Inspection of Books and Records
 
Under the DGCL, any stockholder may, upon written demand under oath stating the purpose thereof, inspect the corporation's books and records for a proper purpose during the usual hours for business.
 
Shareholders of a Cayman Islands company do not have any general rights to inspect or obtain copies of the list of shareholders or corporate records of a company (other than the register of mortgages and charges and the memorandum and articles of association). Under Zhong Yuan’s articles of association, the directors have the discretion as to whether, to what extent, when, where and under what conditions or regulations the accounts and books of the company or any of them shall be open to the inspection of members who are not directors.
       
 
The Company’s bylaws provide that a list of stockholders shall be open to the examination of any stockholder before any meeting of the stockholders for any purpose germane to the meeting during ordinary business hours, for a period of at least ten (10) days prior to the meeting. The list may also be inspected by any stockholder who is present at a meeting of stockholders.
 
The Companies Law requires that the register of mortgages and charges of a corporation be open to inspection by any shareholder or creditor of the company at all reasonable times.
 
 
 
27


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
  Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Amendment of Governing Documents
 
Under the DGCL, a certificate of incorporation may be amended if: (1) the board of directors sets forth the proposed amendment in a resolution, declares the advisability of the amendment and directs that it be submitted to a vote at a meeting of stockholders; and (2) the holders of a majority of shares of stock entitled to vote on the matter approve the amendment, unless the certificate of incorporation requires the vote of a greater number of shares. The Company’s certificate of incorporation is silent as to the vote required to amend the certificate of incorporation.
 
The Companies Law and Zhong Yuan’s articles of association provide that Zhong Yuan’s memorandum of association and articles of association may only be amended by passing a special resolution of its shareholders to effect such amendment.
       
 
In addition, under the DGCL, the holders of the outstanding shares of a class are entitled to vote as a class on an amendment, whether or not entitled to vote thereon by the certificate of incorporation, if the amendment adversely affects the terms of the shares of a class. Class voting rights do not exist as to other extraordinary matters, unless the certificate of incorporation provides otherwise. The Company’s certificate of incorporation does not have such alternate provisions.
 
  
       
 
Under the DGCL, the board of directors may amend a corporation’s bylaws if so authorized in the certificate of incorporation. The Company’s certificate of incorporation and bylaws authorize the board of directors to amend the Company’s bylaws. The Company’s stockholders also have the power to amend bylaws under the company’s bylaws and the DGCL.
 
 

Indemnification of Directors and Officers
 
Under the DGCL, a corporation is generally permitted to indemnify its directors and officers against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with any action, other than an action brought on behalf of the corporation, and against expenses actually and reasonably incurred in the defense or settlement of a derivative action, provided that there is a determination that the individual acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation. That determination must be made by: (1) a majority of the disinterested directors, even though less than a quorum; (2) a committee of disinterested directors designated by a majority vote of disinterested directors, even though less than a quorum; (3) independent legal counsel, if there are no disinterested directors or if the disinterested directors so direct regardless of whether a quorum of disinterested directors exists; or (4) the stockholders.
 
Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.
       
 
Without court approval, however, no indemnification may be made in respect of any derivative action in which an individual is adjudged liable to the corporation.
 
Zhong Yuan’s articles of association provide that its directors and officers shall be indemnified against all actions, proceedings, costs, charges, expenses, losses, damages and liabilities incurred or sustained by such director or officer, other than by reason of such person’s own dishonesty, willful default or fraud, in or about the conduct of Zhong Yuan’s business or affairs or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning Zhong Yuan or its affairs in any court whether in the Cayman Islands or elsewhere.
 
 
 
28


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
  Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
  
 
The DGCL requires indemnification of directors and officers for expenses relating to a successful defense on the merits or otherwise of a derivative or third-party action. Under the DGCL, a corporation may advance expenses relating to the defense of any proceeding to directors and officers contingent upon those individuals' commitment to repay any advances, unless it is determined ultimately that those individuals are entitled to be indemnified.
 
  
         
  
 
The Company’s certificate of incorporation and bylaws provide for indemnification of directors and officers to the fullest extent permitted by law. The bylaws provide for advancement of expenses to defend claims against directors and officers. Further, the Company has indemnification agreements with its directors, officers and certain other employees which provide rights and benefits in addition to those described above.
   
         
Limited Liability of Directors
 
The DGCL permits the adoption of a provision in a corporation's certificate of incorporation limiting or eliminating the monetary liability of a director to a corporation or its stockholders by reason of a director's breach of the fiduciary duty of care. The DGCL does not permit any limitation of the liability of a director for: (1) breaching the duty of loyalty to the corporation or its stockholders; (2) failing to act in good faith; (3) engaging in intentional misconduct or a knowing violation of law; (4) obtaining an improper personal benefit from the corporation; or (5) paying a dividend or approving a stock repurchase or redemption that was illegal under applicable law.
 
Cayman Islands law, in certain circumstances, permits a company to limit the liability of a director to the company. The considerations under Cayman Islands law with regard to the limitation of a director’s liability are similar to those that apply to the enforcement of provisions relating to the indemnification of directors discussed above under “Indemnification of Directors and Officers.” A Cayman Islands court will enforce such a limitation except to the extent that enforcement of the relevant provision may be held to be contrary to public policy.
       
 
The Company’s certificate of incorporation provides that, to the fullest extent permitted by the DGCL, directors are not personally liable to the company or its stockholders for monetary damages for breach of fiduciary duty as a director.
 
Zhong Yuan’s articles of association provide that no current or former director and officer of the company shall be liable to the company for any loss or damage incurred by the company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through such person’s own willful neglect or default.
 
 
 
29


 
   
DGCL/The Company’s Certificate of Incorporation and Bylaws
  Companies Law/Zhong Yuan’s Memorandum of Association and Articles of Association
Stockholder/Shareholder Lawsuits
 
Under the DGCL, a stockholder bringing a derivative suit must have been a stockholder at the time of the wrong complained of or that the stock was transferred to him by operation of law from a person who was such a stockholder. In addition, the stockholder must remain a stockholder throughout the litigation. There is no requirement under the DGCL to advance the expenses of a lawsuit to a stockholder.
 
In the Cayman Islands, the decision to institute proceedings on behalf of a company is generally taken by the company’s board of directors. In certain limited circumstances, a shareholder may be entitled to bring a derivative action on behalf of Zhong Yuan. However, the consideration of such suits has been limited. In this regard, the Cayman Islands courts ordinarily would permit a claim to be brought by a minority shareholder, in respect of a cause of action vested in a Cayman Islands company, in the name of and seeking relief on behalf of the company only (1) in respect of a cause of action arising from an actual or proposed act or omission involving negligence, default, breach of duty or breach of trust by a director of a company; (2) where the act complained of is illegal or alleged to constitute a fraud against the company or against any minority shareholder; or (3) where the act is beyond the corporate power of the company or otherwise requires approval by a greater percentage of the company’s shareholders than actually approved it; and, in each case, where the act complained of is not capable of subsequent ratification by any majority of the company’s shareholders at a general meeting. The cause of action may be against the director, another person or both.
       
 
Under the DGCL, an individual may also commence a class action suit on behalf of himself or herself and other similarly situated stockholders where the requirements for maintaining a class action under Delaware law have been met.
 
A shareholder may also be permitted to bring an action in his or her own name against a Cayman Islands company, a director or any other person in respect of any direct loss suffered by such shareholder as a result of any negligence, default, breach of duty or breach of trust. In any such action, however, a loss suffered by the company will not be regarded as a direct loss suffered by the individual shareholder. A shareholder may also be permitted to bring an action on the basis that the company’s affairs are being, or have been, conducted in a manner that is unfairly prejudicial to the interests of shareholders generally or to some shareholders in particular.


30


ENFORCEABILITY OF CIVIL LIABILITIES

Zhong Yuan is incorporated in the Cayman Islands because of certain benefits associated with being a Cayman Islands company, such as political and economic stability, an effective judicial system, a favorable tax system, the absence of foreign exchange control or currency restrictions and the availability of professional and support services. However, the Cayman Islands has a less developed body of securities laws as compared to the United States and provides less protection for investors. In addition, Cayman Islands companies do not have standing to sue before the federal courts of the United States.

We anticipate that, subsequent to a merger with or acquisition of an operating company, substantially all of Zhong Yuan’s assets will be located outside the United States. In addition, all of Zhong Yuan’s directors and officers are expected to be nationals or residents of jurisdictions other than the United States and all or a substantial portion of their assets are expected to be located outside the United States. As a result, it may be difficult for investors to effect service of process within the United States upon Zhong Yuan or these persons, or to bring an action against Zhong Yuan or against these persons in the United States, in the event that you believe that your rights have been infringed under the securities laws of the United States or any state in the United States. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against Zhong Yuan and its officers and directors. Zhong Yuan has appointed Schlueter & Associates, P.C. as its agent to receive service of process in the United States.

We believe that that there is uncertainty as to whether the courts of the Cayman Islands would (1) recognize or enforce judgments of U.S. courts obtained against Zhong Yuan or its directors or officers, predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States, or (2) entertain original actions brought in the Cayman Islands against Zhong Yuan or its directors or officers, predicated upon the securities laws of the United States or any state in the United States.

We believe that although there is no statutory enforcement in the Cayman Islands of judgments obtained in the federal or state courts of the United States (and the Cayman Islands are not a party to any treaties for the reciprocal enforcement or recognition of such judgments), a judgment obtained in such jurisdiction will be recognized and enforced in the courts of the Cayman Islands at common law, without any re-examination of the merits of the underlying dispute, by an action commenced on the foreign judgment debt in the Grand Court of the Cayman Islands, provided such judgment (a) is given by a foreign court of competent jurisdiction, (b) imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given, (c) is final, (d) is not in respect of taxes, a fine or a penalty, (e) is not inconsistent with a Cayman Islands judgment of the same matter; (f) is not impeachable on grounds of fraud, and (g) was not obtained in a manner and is not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands. However, the Cayman Islands courts are unlikely to enforce a judgment obtained from the U.S. courts under civil liability provisions of the U.S. federal securities law if such judgment is determined by the courts of the Cayman Islands to give rise to obligations to make payments that are penal or punitive in nature. Because such a determination has not yet been made by a court of the Cayman Islands, it is uncertain whether such civil liability judgments from U.S. courts would be enforceable in the Cayman Islands.
 
31

VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF

Voting Securities.

The securities that would have been entitled to vote if a meeting were required to have been held regarding the Redomicile Merger consist of shares of our Common Stock.  Each share of our Common Stock is entitled to one vote.  The record date for determining our stockholders who would have been entitled to notice of and to vote on the Redomicile Merger, was November 15, 2017.   The number of outstanding shares of our Common Stock at the close of business on November 15, 2017 was 8,500,000.

Security Ownership of Principal Holders and Management.

The following table sets forth certain information regarding the beneficial ownership of our Common Stock as of November 15, 2017 by (i) each person known by us to own more than 5% of the outstanding shares of our Common Stock, (ii) each of our executive officers and directors, and (iii) all of our executive officers and directors as a group.  Except as noted, each person has sole voting and sole investment or dispositive power with respect to the shares shown.  The information presented is based on 8,500,000 outstanding shares of Common Stock.

Name and Address of
Beneficial Owner
Amount of Beneficial Ownership
Percent of Beneficial Ownership
CHANG Ting Ting (1)
Suite 2432, Sun Hung Kai Centre
30 Harbour Road
Wanchai, Hong Kong
8,000,000
94.1%
Officers & Directors as a Group
8,000,000
94.1%
(1) Ms. Chang is the sole officer and director of the Company.
ADDITIONAL INFORMATION

This Company is subject to the information requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith files reports and other information including annual and quarterly reports on Form 10-K and Form 10-Q with the Securities and Exchange Commission.  Reports and other information filed by us can be inspected and copied at the public reference facilities maintained at the Securities and Exchange Commission at Room 1024, 450 Fifth Street, N.W., Washington, DC 20549.  Copies of such material can be obtained upon written request addressed to the Securities and Exchange Commission, Public Reference Section, 450 Fifth Street, N.W., Washington, DC 20549, at prescribed rates.  The Securities and Exchange Commission also maintains a web site on the internet (http://www.sec.gov) where reports, proxy and information statements and other information regarding issuers that file electronically with the Securities and Exchange Commission through the Electronic Data Gathering, Analysis and Retrieval System may be obtained free of charge.


 
 
 
 
 
32
Exhibit A
 
 

THE COMPANIES LAW (2016 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION
OF
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Adopted by a Special Resolution passed on November 15, 2017.


1.   The name of the Company is ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED.

2.   The registered office of the Company shall be at the offices of Vistra (Cayman) Limited, P. O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KYI–1205 Cayman Islands, or at such other place as the Directors may from time to time decide.
3.   The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the Companies Law (2016 Revision) or as the same may be revised from time to time, or any other law of the Cayman Islands.
4.   The liability of each Member is limited to the amount from time to time unpaid on such Member’s shares.
5.   The authorized share capital of the Company is US$50,000 divided into 500,000,000 shares of a nominal or par value of US$0.0001 each. The Company has the power to redeem or purchase any of its shares and to increase or reduce the said capital subject to the provisions of the Companies Law (2016 Revision) and the Articles of Association and to issue any part of its capital, whether original, redeemed or increased with or without any preference, priority or special privilege or subject to any postponement of rights or to any conditions or restrictions and so that unless the conditions of issue shall otherwise expressly declare every issue of shares whether declared to be preference or otherwise shall be subject to the powers hereinbefore contained.
6.   The Company has the power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.
7.   Capitalized terms that are not defined in this Memorandum of Association bear the same meaning as those given in the Articles of Association of the Company.
 
1

THE COMPANIES LAW (2016 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
AMENDED AND RESTATED ARTICLES OF ASSOCIATION
OF
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Adopted by a Special Resolution passed on November 15, 2017.

INTERPRETATION
1.  In these Articles, Table A in the Schedule in the Companies Law does not apply and unless otherwise defined, the defined terms shall have the meanings assigned to them as follows:

Articles
 
 
these Articles of Association of the Company as altered or added to, from time to time;
 
       
“Board” or
“Board of Directors”
 
the board of Directors for the time being of the Company;
 
       
“Business Day”
  
a day (excluding Saturdays or Sundays), on which banks in Hong Kong, and New York are open for general banking business throughout their normal business hours;
 
     
Chairman
  
the Chairman appointed pursuant to Article 81;
 
     
Commission
  
Securities and Exchange Commission of the United States of America or any other federal agency for the time being administering the Securities Act of 1933, as amended (“Securities Act”) or the Securities Exchange Act of 1934, as amended (“Exchange Act”);
 
     
Companies Law
  
the Companies Law (2016 Revision) of the Cayman Islands and any statutory amendment or re-enactment thereof. Where any provision of the Companies Law is referred to, the reference is to that provision as amended by any law for the time being in force;
 
     
Company
  
Zhong Yuan Bio-Technology Holdings Limited., a Cayman Islands company limited by shares;
 
     
Company’s Website
  
the website of the Company, if any, the address or domain name of which has been notified to Members;
 
Designated Stock Exchange
  
any of the markets of The Nasdaq Stock Market, The New York Stock Exchange, the NYSE American or any other internationally recognized stock exchange where the Company’s securities are traded;
 
 
 
2

 
 
Directors
  
the directors of the Company for the time being, or as the case may be, the Directors assembled as a Board or as a committee thereof;
   
electronic
  
the meaning given to it in the Electronic Transactions Law (2003 Revision) of the Cayman Islands and any amendment thereto or re-enactments thereof for the time being in force and includes every other law incorporated therewith or substituted therefor;
   
electronic communication
  
electronic posting to the Company’s Website, transmission to any number, address or internet website or other electronic delivery methods as otherwise decided and approved by not less than two-thirds of the vote of the Board;
   
in writing
  
includes writing, printing, lithograph, photograph, type-writing and every other mode of representing words or figures in a legible and non-transitory form and, only where used in connection with a notice served by the Company on Members or other persons entitled to receive notices hereunder, shall also include a record maintained in an electronic medium which is accessible in visible form so as to be useable for subsequent reference;
   
Member ” or “ Shareholder
  
a person who is registered as the holder of Shares in the Register of Members;
   
Memorandum of Association
  
the Memorandum of Association of the Company, as amended and re-stated from time to time;
   
month
  
calendar month;
 
 
 
3

 
   
Ordinary Resolution
  
a resolution:
 
(a) passed by a simple majority of votes cast by such Members as, being entitled to do so, vote in person or, in the case of any Member being an organization, by its duly authorized representative or, where proxies are allowed, by proxy at a general meeting of the Company; or
 
(b) approved in writing by those Members holding a simple majority of all votes entitled to be cast by the Members entitled to vote at a general or special meeting of the Company in one or more instruments each signed by one or more of the Members and the effective date of the resolution so adopted shall be the date on which the instrument, or the last of such instruments if more than one, is executed;
   
paid up
  
paid up as to the par value and any premium payable in respect of the issue of any shares and includes credited as paid up;
   
“Person”
an individual, corporation, joint venture, enterprise, partnership, trust, unincorporated association, limited liability company, government or any department or agency thereof, or any other entity (whether or not having separate legal personality).
   
Register of Members
  
the register to be kept by the Company in accordance with the Companies Law;
   
seal
  
the Common Seal of the Company (if adopted) including any facsimile thereof;

Securities Act
  
the Securities Act of 1933, as amended of the United States of America,  or any similar federal statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time;
   
share
  
any share in the capital of the Company and includes a fraction of a share;
   
signed
  
includes a signature or representation of a signature affixed by mechanical means or an electronic symbol or process attached to or logically associated with an electronic communication and executed or adopted by a person with the intent to sign the electronic communication;
 
 
 
4

 
   
Special Resolution
  
a special resolution of the Company passed in accordance with the Companies Law, being a resolution:
 
(a)   passed by a majority of not less than two-thirds of such Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of the Company of which notice specifying the intention to propose the resolution as a special resolution has been duly given and where a poll is taken regard shall be had in computing a majority to the number of votes to which each Member is entitled; or
 
(b)  approved in writing by all of the Members entitled to vote at a general or special meeting of the Company in one or more instruments each signed by one or more of the Members and the effective date of the special resolution so adopted shall be the date on which the instrument or the last of such instruments, if more than one, is executed;
   
Statutes
  
the Companies Law and every other laws and regulations of the Cayman Islands for the time being in force concerning companies and affecting the Company;
   
year
  
calendar year.
 

2.   In these Articles, save where the context requires otherwise:

(a)  words importing the singular number shall include the plural number and vice versa;

(b)  words importing the masculine gender only shall include the feminine gender;

(c)  words importing persons only shall include companies or associations or bodies of persons, whether corporate or not;

 
(d)
“MAY” shall be construed as permissive and “SHALL” shall be construed as imperative;
 
 
(e)
a reference to a dollar or dollars (or $) is a reference to dollars of the United States;
 
 
(f)
references to a statutory enactment shall include reference to any amendment or re-enactment thereof for the time being in force;
 
 
(g)
any phrase introduced by the terms “including,” “include,” “in particular” or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms; and
 
 
(h)
Section 8 of the Electronic Transactions Law (2003 Revision) shall not apply.
 
 
5


 
3.
Subject to the last two preceding Articles, any words defined in the Companies Law shall, if not inconsistent with the subject or context, bear the same meaning in these Articles.
PRELIMINARY
 
4.
The business of the Company may be conducted as the Directors see fit.

5.
The registered office of the Company shall be at such address in the Cayman Islands as the Directors shall from time to time determine. The Company may in addition establish and maintain such other offices and places of business and agencies in such places as the Directors may from time to time determine.
ISSUE OF SHARES
 
6.
Subject to the provisions, if any, in the Memorandum of Association, these Articles and to any direction that may be given by the Company in a general meeting, the Directors may, in their absolute discretion and without approval of the existing Members, issue shares, grant rights over existing shares or issue other securities in one or more series as they deem necessary and appropriate and determine designations, powers, preferences, privileges and other rights, including dividend rights, conversion rights, terms of redemption and liquidation preferences, any or all of which may be greater than the powers and rights associated with the shares held by existing Members, at such times and on such other terms as they think proper. The Company shall not issue shares in bearer form.
 
7.
The Directors may provide, out of the unissued shares, for series of preferred shares. Before any preferred shares of any such series are issued, the Directors shall fix, by resolution or resolutions, the following provisions of the preferred shares thereof:
 
 
(a)
the designation of such series, the number of preferred shares to constitute such series and the subscription price thereof if different from the par value thereof;
 
 
(b)
whether the shares of such series shall have voting rights, in addition to any voting rights provided by law, and, if so, the terms of such voting rights, which may be general or limited;
 
 
(c)
the dividends, if any, payable on such series, whether any such dividends shall be cumulative, and, if so, from what dates, the conditions and dates upon which such dividends shall be payable, the preference or relation which such dividends shall bear to the dividends payable on any shares of any other class or any other series of preferred shares;
 
 
 
6

 
 
(d)
whether the preferred shares of such series shall be subject to redemption by the Company, and, if so, the times, prices and other conditions of such redemption;
 
 
(e)
the amount or amounts payable upon preferred shares of such series upon, and the rights of the holders of such series in, a voluntary or involuntary liquidation, dissolution or winding up, or upon any distribution of the assets, of the Company;
 
 
(f)
whether the preferred shares of such series shall be subject to the operation of a retirement or sinking fund and, if so, the extent to and manner in which any such retirement or sinking fund shall be applied to the purchase or redemption of the preferred shares of such series for retirement or other corporate purposes and the terms and provisions relative to the operation thereof;
 
 
(g)
whether the preferred shares of such series shall be convertible into, or exchangeable for, shares of any other class or any other series of preferred shares or any other securities and, if so, the price or prices or the rate or rates of conversion or exchange and the method, if any, of adjusting the same, and any other terms and conditions of conversion or exchange;
 
 
(h)
the limitations and restrictions, if any, to be effective while any preferred shares of such series are outstanding upon the payment of dividends or the making of other distributions on, and upon the purchase, redemption or other acquisition by the Company of, the existing shares or shares of any other class of shares or any other series of preferred shares;
 
 
(i)
the conditions or restrictions, if any, upon the creation of indebtedness of the Company or upon the issue of any additional shares, including additional shares of such series or of any other class of shares or any other series of preferred shares; and
 
 
(j)
any other powers, preferences and relative, participating, optional and other special rights, and any qualifications, limitations and restrictions thereof.
Without limiting the foregoing and subject to Article 81, the voting powers of any series of preferred shares may include the right, in the circumstances specified in the resolution or resolutions providing for the issuance of such preferred shares, to elect one or more Directors who shall serve for such term and have such voting powers as shall be stated in the resolution or resolutions providing for the issuance of such preferred shares. The term of office and voting powers of any Director elected in the manner provided in the immediately preceding sentence of this Article 7 may be greater than or less than those of any other Director or class of Directors.
 
8.
The powers, preferences and relative, participating, optional and other special rights of each series of preferred shares, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding. All shares of any one series of preferred shares shall be identical in all respects with all other shares of such series, except that shares of any one series issued at different times may differ as to the dates from which dividends thereon shall be cumulative.
 
7

REGISTER OF MEMBERS AND SHARE CERTIFICATES
 
9.
The Company shall maintain a register of its Members and a Member shall only be entitled to a share certificate if the Directors resolve that share certificates shall be issued. Share certificates (if any) shall specify the share or shares held by that person and the amount paid up thereon, provided that in respect of a share or shares held jointly by several persons the Company shall not be bound to issue more than one certificate, and delivery of a certificate for a share to one of several joint holders shall be sufficient delivery to all. All certificates for shares shall be delivered personally or sent through the post addressed to the Member entitled thereto at the Member’s registered address as appearing in the Register of Members.
 
10.
All share certificates shall bear legends required under the applicable laws, including the Securities Act.
 
11.
Any two or more certificates representing shares of any one class held by any Member may at the Member’s request be cancelled and a single new certificate for such shares issued in lieu on payment (if the Directors shall so require) of US$1.00 or such smaller sum as the Directors shall determine.
 
12.
If a share certificate shall be damaged or defaced or alleged to have been lost, stolen or destroyed, a new certificate representing the same shares may be issued to the relevant Member upon request subject to delivery up of the old certificate or (if alleged to have been lost, stolen or destroyed) compliance with such conditions as to evidence and indemnity and the payment of out-of-pocket expenses of the Company in connection with the request as the Directors may think fit.
 
13.
In the event that shares are held jointly by several persons, any request may be made by any one of the joint holders and if so made shall be binding on all of the joint holders.
 
TRANSFER OF SHARES
 
14.
(a) Shares are transferable subject to the approval of the Board or the written consent of a Director authorized by the Board in writing to approve share transfers and the Board may, in its sole discretion, decline to register any transfer of any share which is not fully paid up or on which the Company has a lien, or which is not in compliance with the applicable provisions of the Securities Act, the Exchange Act, or other US federal and state securities laws.
 
 
(b)
The Directors may also decline to register any transfer of any share unless:
 
 
(i)
the instrument of transfer is lodged with the Company, accompanied by the certificate for the shares to which it relates and such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer;
 
 
(ii)
the instrument of transfer is in respect of only one class of shares;
 
 
 
8

 
 
(iii)
the instrument of transfer is properly stamped, if required;
 
 
(iv)
in the case of a transfer to joint holders, the number of joint holders to whom the share is to be transferred does not exceed four;
 
 
(v)
the shares conceded are free of any lien in favor of the Company; or
 
 
(vi)
a fee of such maximum sum as the Designated Stock Exchange may determine to be payable, or such lesser sum as the Board may from time to time require, is paid to the Company in respect thereof.
 
 
(c)
If the Directors refuse to register a transfer they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.
 
15.
The registration of transfers may, on 14 days’ notice being given by advertisement in such one or more newspapers or by electronic means, be suspended and the register closed at such times and for such periods as the Board may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year.
 
16.
The instrument of transfer of any share shall be in writing and executed by or on behalf of the transferor (and if the Directors so require, signed by the transferee). The transferor shall be deemed to remain a holder of the share until the name of the transferee is entered in the Register of Members.
 
17.
All instruments of transfer that shall be registered shall be retained by the Company.
REDEMPTION AND PURCHASE OF OWN SHARES
 
18.
Subject to the provisions of the Statutes and these Articles, the Company may:
 
 
(a)
issue shares on terms that they are to be redeemed or are liable to be redeemed at the option of the Company or the Member and the redemption of shares shall be effected on such terms and in such manner as the Board may, before the issue of such shares, determine;
 
 
(b)
purchase its own shares (including any redeemable shares) provided that the Members shall have approved the manner of purchase by Ordinary Resolution or the manner of purchase is in accordance with Articles 19 and 20 (this authorization is in accordance with section 37(2) of the Statutes or any modification or re-enactment thereof for the time being in force); and
 
 
(c)
the Company may make a payment in respect of the redemption or purchase of its own shares in any manner permitted by the Statutes, including out of capital.
 
 
9

 
19.
Purchase of shares listed on the Designated Stock Exchange: the Company is authorized to purchase any share listed on the Designated Stock Exchange in accordance with the following manner of purchase:
 
 
(a)
the maximum number of shares that may be repurchased shall be equal to the number of issued and outstanding shares less one share; and
 
 
(b)
the repurchase shall be at such time, at such price and on such other terms as determined and agreed by the Board in their sole discretion provided however that:
 
 
(i)
such repurchase transactions shall be in accordance with the relevant code, rules and regulations applicable to the listing of the shares on the Designated Stock Exchange; and
 
 
(ii)
at the time of the repurchase, the Company is able to pay its debts as they fall due in the ordinary course of its business.
 
20.
Purchase of shares not listed on the Designated Stock Exchange: the Company is authorized to purchase any shares not listed on the Designated Stock Exchange in accordance with the following manner of purchase:
 
 
(a)
the Company shall serve a repurchase notice in a form approved by the Board on the Member from whom the shares are to be repurchased at least two Business Days prior to the date specified in the notice as being the repurchase date;
 
 
(b)
the price for the shares being repurchased shall be such price agreed between the Board and the applicable Member;
 
 
(c)
the date of repurchase shall be the date specified in the repurchase notice; and
 
 
(d)
the repurchase shall be on such other terms as specified in the repurchase notice as determined and agreed by the Board and the applicable Member in their sole discretion.
 
21.
The redemption or purchase of any share shall not be deemed to give rise to the redemption or purchase of any other share and the Company is not obligated to purchase any other share other than as may be required pursuant to applicable law and any other contractual obligations of the Company.
 
22.
The holder of the shares being purchased shall be bound to deliver up to the Company the certificate(s) (if any) thereof for cancellation and thereupon the Company shall pay to him the purchase or redemption monies or consideration in respect thereof.
 
10

VARIATION OF RIGHTS ATTACHING TO SHARES
 
23.
If at any time the share capital is divided into different classes or series of shares, the rights attaching to any class or series (unless otherwise provided by the terms of issue of the shares of that class or series) may, subject to these Articles, be varied or abrogated with the consent in writing of the holders of a majority of the issued shares of that class or series or with the sanction of a Special Resolution passed at a general meeting of the holders of the shares of that class or series or by Special Resolution signed by all of the Members of that class or series entitled to vote.
 
24.
The provisions of these Articles relating to general meetings shall apply to every such general meeting of the holders of one class or series of shares except the following:
 
 
(a)
separate general meetings of the holders of a class or series of shares may be called only by (i) the Chairman of the Board, or (ii) a majority of the entire Board of Directors (unless otherwise specifically provided by the terms of issue of the shares of such class or series). Nothing in this Article 24 or Article 23 shall be deemed to give any Member or Members the right to call a class or series meeting.
 
 
(b)
the necessary quorum shall be one or more persons holding or representing by proxy at least one-third of the issued shares of the class or series and any holder of shares of the class or series present in person or by proxy may demand a poll.
 
25.
The rights conferred upon the holders of the shares of any class or series shall not, unless otherwise expressly provided by the terms of issue of the shares of that class or series, be deemed to be varied by the creation or issue of further shares ranking in priority thereto or pari passu therewith.
COMMISSION ON SALE OF SHARES
 
26.
The Company may in so far as the Statutes from time to time permit pay a commission to any person in consideration of his subscribing or agreeing to subscribe whether absolutely or conditionally for any shares of the Company. Such commissions may be satisfied by the payment of cash or the lodgement of fully or partly paid-up shares or partly in one way and partly in the other. The Company may also on any issue of shares pay such brokerage as may be lawful.

11



NON-RECOGNITION OF TRUSTS
 
27.
No person shall be recognized by the Company as holding any share upon any trust and the Company shall not be bound by or be compelled in any way to recognize (even when having notice thereof) any equitable, contingent, future or partial interest in any share, or any interest in any fractional part of a share, or (except only as is otherwise provided by these Articles or the Statutes) any other rights in respect of any share except an absolute right to the entirety thereof in the registered holder, provided that, notwithstanding the foregoing, the Company shall be entitled to recognise any such interests as shall be determined by the Directors..
LIEN ON SHARES
 
28.
The Company shall have a first and paramount lien and charge on all shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such share shall operate as a waiver of the Company’s lien (if any) thereon. The Company’s lien (if any) on a share shall extend to all dividends or other monies payable in respect thereof.
 
29.
The Company may sell, in such manner as the Directors think fit, any shares on which the Company has a lien, but no sale shall be made unless some sum in respect of which the lien exists is presently payable nor until the expiration of 14 calendar days after a notice in writing, stating and demanding payment of such part of the amount in respect of which the lien exists as is presently payable, has been given to the registered holder for the time being of the share, or the persons entitled thereto by reason of his death or bankruptcy.
 
30.
For giving effect to any such sale the Directors may authorize some person to transfer the shares sold to the purchaser thereof. The purchaser shall be registered as the holder of the shares comprised in any such transfer and he shall not be bound to see to the application of the purchase money, nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings in reference to the sale.
 
31.
The proceeds of the sale shall be received by the Company and applied in payment of such part of the amount in respect of which the lien exists as is presently payable, and the residue shall (subject to a like lien for sums not presently payable as existed upon the shares prior to the sale) be paid to the person entitled to the shares at the date of the sale.


12

CALLS ON SHARES
 
32.
Subject to the terms of allotment, the Directors may from time to time make calls upon the Members in respect of any money unpaid on their shares, and each Member shall (subject to receiving at least 14 calendar days notice specifying the time or times of  payment) pay to the Company at the time or times so specified the amount called on his shares. A call shall be deemed to have been made at the time when the resolution of the Directors authorizing such call was passed.
  
33.
The joint holders of a share shall be jointly and severally liable to pay calls in respect thereof.
 
34.
If a sum called in respect of a share is not paid before or on the day appointed for payment thereof, the person from whom the sum is due shall pay interest upon the sum at the rate of eight percent per annum from the day appointed for the payment thereof to the time of the actual payment, but the Directors shall be at liberty to waive payment of that interest wholly or in part.
 
35.
The provisions of these Articles as to the liability of joint holders and as to payment of interest shall apply in the case of non-payment of any sum which, by the terms of issue of a share, becomes payable at a fixed time, whether on account of the amount of the share, or by way of premium, as if the same had become payable by virtue of a call duly made and notified.
 
36.
The Directors may make arrangements on the issue of shares for a difference between the Members, or the particular shares, in the amount of calls to be paid and in the times of payment.
 
37.
The Directors may, if they think fit, receive from any Member willing to advance the same all or any part of the monies uncalled and unpaid upon any shares held by him, and upon all or any of the monies so advanced may (until the same would, but for such advance, become presently payable) pay interest at such rate (not exceeding without the sanction of an Ordinary Resolution, eight percent per annum) as may be agreed upon between the Member paying the sum in advance and the Directors. No such sum paid in advance of calls shall entitle the Member paying such sum to any portion of a dividend declared in respect of any period prior to the date upon which such sum would, but for such payment, become presently payable.
FORFEITURE OF SHARES
 
38.
If a Member fails to pay any call or installment of a call on the day appointed for payment thereof, the Directors may, at any time thereafter during such time as any part of such call or installment remains unpaid, serve a notice on him requiring payment of such amount of the call or installment as is unpaid, together with any interest which may have accrued.
 
39.
The notice shall name a further day (not earlier than the expiration of 14 calendar days from the date of the notice) on or before which the payment required by the notice is to be made, and shall state that in the event of non-payment at or before the time appointed the shares in respect of which the call was made will be liable to be forfeited.
 
 
13

 
40.
If the requirements of any such notice as aforesaid are not complied with, any share in respect of which the notice has been given may at any time thereafter, before the payment required by notice has been made, be forfeited by a resolution of the Directors to that effect.
 
41.
A forfeited share may be sold or otherwise disposed of on such terms and in such manner as the Directors think fit, and at any time before a sale or disposition the forfeiture may be cancelled on such terms as the Directors think fit.
 
42.
A person whose shares have been forfeited shall cease to be a Member in respect of the forfeited shares, but shall, notwithstanding, remain liable to pay to the Company all monies which at the date of forfeiture were payable by him to the Company in respect of the shares, but his liability shall cease if and when the Company receives payment in full of the fully paid up amount of the shares.
 
43.
A certificate in writing under the hand of a Director of the Company, which certifies that a share has been forfeited on a date stated in the certificate, shall be conclusive evidence of the facts therein stated as against all persons claiming to be entitled to the share. The Company may receive the consideration, if any, given for the share or any sale or disposition thereof and may execute a transfer of the share in favor of the person to whom the share is sold or disposed of and he shall thereupon be registered as the holder of the share, and shall not be bound to see to the application of the purchase money, if any, nor shall his title to the share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the share.
 
44.
The provisions of these Articles as to forfeiture shall apply in the case of non-payment of any sum which by the terms of issue of a share becomes due and payable, whether on account of the amount of the share, or by way of premium, as if the same had been payable by virtue of a call duly made and notified.
REGISTRATION OF EMPOWERING INSTRUMENTS
 
45.
The Company shall be entitled to charge a fee not exceeding one dollar (US$1.00) on the registration of every probate, letters of administration, certificate of death or marriage, power of attorney, notice in lieu of distringas or other instrument.


14

TRANSMISSION OF SHARES
 
46.
The legal personal representative of a deceased sole holder of a share shall be the only person recognized by the Company as having any title to the share. In the case of a share registered in the name of two or more holders, the survivors or survivor, or the legal personal representatives of the deceased survivor, shall be the only person recognized by the Company as having any title to the share.
 
47.
Any person becoming entitled to a share in consequence of the death or bankruptcy of a Member shall upon such evidence being produced as may from time to time be properly required by the Directors, have the right either to be registered as a Member in respect of the share or, instead of being registered himself, to make such transfer of the share as the deceased or bankrupt person could have made. If the person so becoming entitled shall elect to be registered himself as holder he shall deliver or send to the Company a notice in writing signed by him stating that he so elects.
 
48.
A person becoming entitled to a share by reason of the death or bankruptcy of the holder shall be entitled to the same dividends and other advantages to which he would be entitled if he were the registered holder of the share, except that he shall not, before being registered as a Member in respect of the share, be entitled in respect of it to exercise any right conferred by membership in relation to meetings of the Company, provided however, that the Directors may at any time give notice requiring any such person to elect either to be registered himself or to transfer the share, and if the notice is not complied with within 90 calendar days, the Directors may thereafter withhold payment of all dividends, bonuses or other monies payable in respect of the share until the requirements of the notice have been complied with.
 
ALTERATION OF CAPITAL
 
49.
The Company may by Ordinary Resolution:
 
 
(a)
increase the share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe;
 
 
(b)
consolidate and divide all or any of its share capital into shares of larger amount than its existing shares;
 
 
(c)
sub-divide its existing shares or any of them into shares of a smaller amount provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived;
 
 
(d)
cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled.
 
 
15

 
50.
Subject to the provisions of the Statutes and these Articles as regards to the matters to be dealt with by Ordinary Resolution, the Company may by Special Resolution reduce its share capital and any capital redemption reserve in any manner authorized by law.
 
51.
All new shares created hereunder shall be subject to the same provisions with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the shares in the original share capital.
CLOSING REGISTER OF MEMBERS OR FIXING RECORD DATE
 
52.
For the purpose of determining those Members that are entitled to receive notice of, attend or vote at any meeting of Members or any adjournment thereof, or those Members that are entitled to receive payment of any dividend, or in order to make a determination as to who is a Member for any other purpose, the Directors may provide that the Register of Members shall be closed for transfers for a stated period but not to exceed in any case 30 calendar days. If the Register of Members shall be so closed for the purpose of determining those Members that are entitled to receive notice of, attend or vote at a meeting of Members such register shall be so closed for at least 10 calendar days immediately preceding such meeting and the record date for such determination shall be the date of the closure of the Register of Members.
 
53.
In lieu of or apart from closing the Register of Members, the Directors may fix in advance a date as the record date for any such determination of those Members that are entitled to receive notice of, attend or vote at a meeting of the Members and for the purpose of determining those Members that are entitled to receive payment of any dividend, the Directors may, at or within 90 calendar days prior to the date of declaration of such dividend fix a subsequent date as the record date of such determination.

54.
If the Register of Members is not so closed and no record date is fixed for the determination of those Members entitled to receive notice of, attend or vote at a meeting of Members or those Members that are entitled to receive payment of a dividend, the date on which notice of the meeting is posted or the date on which the resolution of the Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of Members. When a determination of those Members that are entitled to receive notice of, attend or vote at a meeting of Members has been made as provided in this section, such determination shall apply to any adjournment thereof.
GENERAL MEETINGS
 
55.
All general meetings of the Company other than annual general meetings shall be called extraordinary general meetings.
 
56.
(a) The Company may hold an annual general meeting and shall specify the meeting as such in the notices calling it. The annual general meeting shall be held at such time and place as the Directors shall determine.
 
 
16


 
 
(b)
At these meetings the report of the Directors (if any) shall be presented.
 
57.
(a) The Directors may call general meetings, and they shall on a Members requisition forthwith proceed to convene an extraordinary general meeting of the Company.
 
 
(b)
A Members requisition is a requisition of Members of the Company holding at the date of deposit of the requisition not less than one-third of the share capital of the Company as at that date carries the right of voting at general meetings of the Company.
 
 
(c)
The requisition must state the objects of the meeting and must be signed by the requisitionists and deposited at the principal place of business of the Company (with a copy forwarded to the registered office), and may consist of several documents in like form each signed by one or more requisitionists.
 
 
(d)
If the Directors do not within 21 calendar days from the date of the deposit of the requisition duly proceed to convene a general meeting to be held within a further 21 calendar days, the requisitionists, or any of them representing more than one half of the total voting rights of all of them, may themselves convene a general meeting, but any meeting so convened shall not be held after the expiration of three months after the expiration of the second said 21 calendar days.
 
 
(e)
A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly as possible as that in which general meetings are to be convened by Directors.
NOTICE OF GENERAL MEETINGS
 
58.
At least seven calendar days’ notice shall be given for any general meeting. Every notice shall be exclusive of the day on which it is given or deemed to be given and of the day for which it is given and shall specify the place, the day and the hour of the meeting and the general nature of the business and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this regulation has been given and whether or not the provisions of these Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:
 
 
(a)
in the case of an annual general meeting by all the Members (or their proxies) entitled to attend and vote thereat; and
 
 
(b)
in the case of an extraordinary general meeting by a majority of the Members (or their proxies) having a right to attend and vote at the meeting, being a majority together holding not less than sixty percent in par value of the shares giving that right.
 
59.
The accidental omission to give notice of a meeting to or the non-receipt of a notice of a meeting by any Member shall not invalidate the proceedings at any meeting.
 
17

PROCEEDINGS AT GENERAL MEETINGS
 
60.
No business shall be transacted at any general meeting unless a quorum of Members is present at the time when the meeting proceeds to business. One or more Members holding not less than an aggregate of one-third of all voting share capital of the Company in issue present in person or by proxy and entitled to vote shall be a quorum for all purposes.
 
61.
If provided for by the Company, a person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general meeting in this manner is treated as presence in person at that meeting.
 
62.
If within half an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition of Members, shall be dissolved. In any other case it shall stand adjourned to the same day in the next week, at the same time and place, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting, the meeting shall be dissolved.
 
63.
The Chairman of the Board of Directors shall preside as chairman at every general meeting of the Company.
 
64.
If at any meeting the Chairman of the Board of Directors is not present within fifteen minutes after the time appointed for holding the meeting or is unwilling to act as chairman, the Directors present shall elect one of their members to be chairman of the meeting, or, if no Director is so elected and willing to be chairman of the meeting, the Members present shall choose a chairman of the meeting.
 
65.
The chairman may with the consent of any meeting at which a quorum is present (and shall if so directed by the meeting) adjourn a meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. When a meeting is adjourned for 10 calendar days or more, not less than 7 Business Days’ notice of the adjourned meeting shall be given as in the case of an original meeting. Save as aforesaid it shall not be necessary to give any notice of an adjournment or of the business to be transacted at an adjourned meeting.
 
66.
At any general meeting a resolution put to the vote of the meeting shall be decided on a show of hands, unless a poll is (before or on the declaration of the result of the show of hands) demanded by one or more Members present in person or by proxy entitled to vote and who together hold not less than 10 percent of the paid up voting share capital of the Company, and unless a poll is so demanded, a declaration by the chairman that a resolution has, on a show of hands, been carried, or carried unanimously, or by a particular majority, or lost, and an entry to that effect in the book of the proceedings of the Company, shall be conclusive evidence of the fact, without proof of the number or proportion of the votes recorded in favour of, or against, that resolution.
 
 
18

 
67.
If a poll is duly demanded it shall be taken in such manner as the chairman directs, and the result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded. The demand for a poll may be withdrawn.
 
68.
In the case of an equality of votes, whether on a show of hands or on a poll, the chairman of the meeting at which the show of hands takes place or at which the poll is demanded, shall be entitled to a second or casting vote.
 
69.
A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such time as the chairman of the meeting directs.
VOTES OF MEMBERS
 
70.
Subject to any rights and restrictions for the time being attached to any class or classes of shares, every Member present in person and every person representing a Member by proxy at a general meeting of the Company shall have one vote for each share registered in his name in the Register of Members.

71.
In the case of joint holders the vote of the senior who tenders a vote whether in person or by proxy shall be accepted to the exclusion of the votes of the joint holders and for this purpose seniority shall be determined by the order in which the names stand in the Register of Members.
 
72.
A Member of unsound mind, or in respect of whom an order has been made by any court having jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee, or other person in the nature of a committee appointed by that court, and any such committee or other person, may on a poll, vote by proxy.
 
73.
No Member shall be entitled to vote at any general meeting unless all calls or other sums presently payable by him in respect of shares in the Company have been paid.
 
74.
On a poll, votes may be given either personally or by proxy.
 
75.
The instrument appointing a proxy shall be in writing under the hand of the appointor or of his attorney duly authorized in writing or, if the appointor is a corporation, either under seal or under the hand of an officer or attorney duly authorized. A proxy need not be a Member of the Company.
 
76.
An instrument appointing a proxy may be in any usual or common form or such other form as the Directors may approve. The instrument appointing a proxy shall be deemed to confer authority to demand or join in demanding a poll.
 
 
19

 
77.
The instrument appointing a proxy shall be deposited at the registered office or at such other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the Company:
 
 
(a)
not less than 48 hours before the time for holding the meeting or adjourned meeting at which the person named in the instrument proposes to vote; or
 
 
(b)
in the case of a poll taken more than 48 hours after it is demanded, be deposited as aforesaid after the poll has been demanded and not less than 24 hours before the time appointed for the taking of the poll; or
 
 
(c)
where the poll is not taken forthwith but is taken not more than 48 hours after it was demanded, be delivered at the meeting at which the poll was demanded to the chairman or to the secretary or to any Director;  provided that the Directors may in the notice convening the meeting, or in an instrument of proxy sent out by the Company, direct that the instrument appointing a proxy may be deposited (no later than the time for holding the meeting or adjourned meeting) at the registered office or at such other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the Company. The chairman may in any event at his discretion direct that an instrument of proxy shall be invalid
 
78.
Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the transfer of the share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer was received by the Company before the commencement of the general meeting, or adjourned meeting at which it is sought to use the proxy.
CORPORATIONS ACTING BY REPRESENTATIVES AT MEETING
 
79.
Any corporation which is a Member may by resolution of its directors or other governing body authorize such person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorized shall be entitled to exercise the same powers on behalf of the corporation which he represents as that corporation could exercise if it were an individual Member.
 
 
 
20

CLEARING HOUSES
 
80.
If a clearing house (or its nominee) is a Member of the Company it may, by resolution of its directors or other governing body or by power of attorney, authorize such person or persons as it thinks fit to act as its representative or representatives at any general meeting of the Company or at any general meeting of any class of Members of the Company provided that, if more than one person is so authorized, the authorization shall specify the number and class of shares in respect of which each such person is so authorized. A person so authorized pursuant to this provision shall be entitled to exercise the same powers on behalf of the clearing house (or its nominee) which he represents as that clearing house (or its nominee) could exercise if it were an individual Member of the Company holding the number and class of shares specified in such authorization.
DIRECTORS
 
81.    (a)    
Unless otherwise determined by the Company in general meeting, the number of Directors shall not be less than one or more than ten Directors. The Directors shall be elected or appointed in the first place by the subscribers to the Memorandum of Association or by a majority of them and thereafter by the Members at general meeting.
 
 
(b)
Each Director shall hold office until the expiration of his term and until his successor shall have been elected and qualified.
 
 
(c)
The Board of Directors shall have a Chairman (the “Chairman”) elected and appointed by a majority of the Directors then in office. The Directors may also elect a Co-Chairman or a Vice-Chairman of the Board of Directors (the “Co-Chairman”). The Chairman shall preside as chairman at every meeting of the Board of Directors. To the extent the Chairman is not present at a meeting of the Board of Directors, the Co-Chairman, or in his absence, the attending Directors may choose one Director to be the chairman of the meeting. The Chairman’s voting right as to the matters to be decided by the Board of Directors shall be the same as other Directors.
 
 
(d)
The Company may by Ordinary Resolution elect any person to be a Director either to fill a casual vacancy on the Board or as an addition to the existing Board.
 
 
(e)
The Directors by the affirmative vote of a simple majority of the remaining Directors present and voting at a Board meeting, or the sole remaining Director, shall have the power from time to time and at any time to appoint any person to serve as a Director to fill a casual vacancy on the Board or as an addition to the existing Board, subject to the Company’s compliance with director nomination procedures required under applicable corporate governance rules of the Designated Stock Exchange, as long as the Company’s securities are traded on the Designated Stock Exchange.
 
82.
Subject to Article 81, a Director may be removed from office by Ordinary Resolution at any time before the expiration of his term.
 
 
21

 
83.
A vacancy on the Board created by the removal of a Director under the provisions of Article 82 above may be filled by the election or appointment by Ordinary Resolution at the meeting at which such Director is removed or by the affirmative vote of a simple majority of the remaining Directors present and voting at a Board meeting.
 
84.
The Board may, from time to time, and except as required by applicable law or the listing rules of the Designated Stock Exchange where the Company’s securities are traded, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives, which shall be intended to set forth the policies of the Company and the Board on various corporate governance related matters as the Board shall determine by resolution from time to time.
 
85.
A Director shall not be required to hold any shares in the Company by way of qualification. A Director who is not a Member of the Company shall nevertheless be entitled to receive notice of and to attend and speak at general meetings of the Company and all classes of shares of the Company.
DIRECTORS’ FEES AND EXPENSES
 
86.
The Directors may receive such remuneration as the Board may from time to time determine. The Directors may be entitled to be repaid all travelling, hotel and incidental expenses reasonably incurred or expected to be incurred by him in attending meetings of the Board or committees of the Board or general meetings or separate meetings of any class of shares or of debentures of the Company or otherwise in connection with the discharge of his duties as a Director.
 
87.
Any Director who, by request, goes or resides abroad for any purpose of the Company or who performs services which in the opinion of the Board go beyond the ordinary duties of a Director may be paid such extra remuneration (whether by way of salary, commission, participation in profits or otherwise) as the Board may determine and such extra remuneration shall be in addition to or in substitution for any ordinary remuneration provided for by or pursuant to any other Article.



22


ALTERNATE DIRECTOR

88.
Any Director may in writing appoint another person to be his alternate to act in his place at any meeting of the Directors at which he is unable to be present. Every such alternate shall be entitled to notice of meetings of the Directors and to attend and vote thereat as a Director when the person appointing him is not personally present and, where he is a Director, to have a separate vote on behalf of the Director he is representing in addition to his own vote. A Director may at any time in writing revoke the appointment of an alternate appointed by him. Such alternate shall be deemed for all purposes to be a Director and shall not be deemed to be the agent of the Director appointing him. An alternate Director shall cease to be an alternate Director if his appointor ceases to be a Director.
 
89.
Any Director may appoint any person, whether or not a Director, to be the proxy of that Director to attend and vote on his behalf, in accordance with instructions given by that Director, or in the absence of such instructions at the discretion of the proxy, at a meeting or meetings of the Directors which that Director is unable to attend personally. The instrument appointing the proxy shall be in writing under the hand of the appointing Director and shall be in any usual or common form or such other form as the Directors may approve, and must be lodged with the chairman of the meeting at which such proxy is to be used, or first used, prior to the commencement of the meeting.
POWERS AND DUTIES OF DIRECTORS
 
90.
Subject to the provisions of the Companies Law, these Articles and to any resolutions made in a general meeting, the business of the Company shall be managed by the Directors, who may pay all expenses incurred in setting up and registering the Company and may exercise all powers of the Company. No resolution made by the Company in a general meeting shall invalidate any prior act of the Directors that would have been valid if that resolution had not been made.
 
91.
Subject to these Articles, the Directors may from time to time appoint any person, whether or not a Director of the Company, to hold such office in the Company as the Directors may think necessary for the administration of the Company, including without prejudice to the foregoing generality, the office of the Chief Executive Officer, Chief Operating Officer, Chief Technology Officer, Chief Financial Officer, one or more Vice Presidents, Manager or Controller, and for such term and at such remuneration (whether by way of salary or commission or participation in profits or partly in one way and partly in another), and with such powers and duties as the Directors may think fit. The Directors may also appoint one or more of their body (but not an alternate Director) to the office of Managing Director upon like terms, but any such appointment shall ipso facto determine if any Managing Director ceases from any cause to be a Director, or if the Company by Ordinary Resolution resolves that his tenure of office be terminated.
 
92.
The Directors may delegate any of their powers to committees consisting of such member or members of their body as they think fit; any committee so formed shall in the exercise of the powers so delegated conform to any regulations that may be imposed on it by the Directors.
 
 
23

 
93.
The Directors may from time to time and at any time by power of attorney appoint any company, firm or person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretion (not exceeding those vested in or exercisable by the Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such power of attorney may contain such provisions for the protection and convenience of persons dealing with any such attorney as the Directors may think fit, and may also authorize any such attorney to delegate all or any of the powers, authorities and discretion vested in him.
 
94.
The Directors may from time to time provide for the management of the affairs of the Company in such manner as they shall think fit and the provisions contained in the following paragraphs shall be without prejudice to the general powers conferred by this paragraph.
 
95.
The Directors from time to time and at any time may establish any committees, local boards or agencies for managing any of the affairs of the Company and may appoint any persons to be members of such committees or local boards and may appoint any managers or agents of the Company and may fix the remuneration of any of the aforesaid.
 
96.
The Directors from time to time and at any time may delegate to any such committee, local board, manager or agent any of the powers, authorities and discretions for the time being vested in the Directors and may authorize the members for the time being of any such local board, or any of them to fill up any vacancies therein and to act notwithstanding vacancies and any such appointment or delegation may be made on such terms and subject to such conditions as the Directors may think fit and the Directors may at any time remove any person so appointed and may annul or vary any such delegation, but no person dealing in good faith and without notice of any such annulment or variation shall be affected thereby.
 
97.
Any such delegates as aforesaid may be authorized by the Directors to sub-delegate all or any of the powers, authorities, and discretions for the time being vested to them.
 
98.
The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and uncalled capital or any part thereof, to issue debentures, debenture stock and other securities whenever money is borrowed or as security for any debt, liability or obligation of the Company or of any third party.
DISQUALIFICATION OF DIRECTORS
 
99.
Notwithstanding anything in these Articles, the office of Director shall be vacated, if the Director:
 
 
(a)
dies, becomes bankrupt or makes any arrangement or composition with his creditors;
 
 
(b)
is found to be or becomes of unsound mind;
 
 
(c)
resigns his office by notice in writing to the Company; or
 
 
(d)
shall be removed from office pursuant to Articles 81 or 82 or the Statutes.
 
24

PROCEEDINGS OF DIRECTORS
 
100.
The Directors may meet together (whether within or outside the Cayman Islands) for the dispatch of business, adjourn and otherwise regulate their meetings and proceedings as they think fit.
 
101.
A Board meeting may be called by a Director by giving notice in writing to the Board specifying a date, time and agenda for such meeting. The Board shall upon receipt of such notice give a copy of such notice of such meeting to all Directors and their respective alternates (if any).
 
102.
(a) At least one (1) Business Day notice shall be given to all Directors and their respective alternates (if any) for a Board meeting, provided that such notice period may be reduced or waived with the consent of all the Directors or their respective alternates (if any).

 
(b)
An agenda identifying in reasonable detail the issues to be considered by the Directors at any such meeting and copies (in printed or electronic form) of any relevant papers to be discussed at the meeting together with all relevant information shall be provided to and received by all Directors and their alternates (if any) at least one (1) Business Day prior to the date for such meeting. The agenda for each meeting shall include any matter submitted to the Company by any Director at least one (1) Business Day prior to the date for such meeting.
 
 
(c)
Unless approved by all Directors (whether or not present or represented at such meeting), matters not set out in the agenda need not be considered at a Board meeting.
 
103.
A Director or Directors may participate in any meeting of the Board of Directors, or of any committee appointed by the Board of Directors of which such Director or Directors are members, by means of conference telephone, video conference or similar communication equipment by way of which all persons participating in such meeting can hear each other and such participation shall be deemed to constitute presence in person at the meeting.
 
104.
The quorum necessary for the transaction of the business of the Directors may be fixed by the Directors and unless so fixed shall be a majority of the Directors then in office, provided that a Director and his appointed alternate Director shall be considered only one person for this purpose .
 
 
25

 
105.
If a quorum is not present at a Board meeting within thirty (30) minutes following the time appointed for such Board meeting, the relevant meeting shall be adjourned for a period of at least three (3) Business Days and the presence of any three (3) Directors shall constitute a quorum at such adjourned meeting. A meeting of the Directors at which a quorum is present when the meeting proceeds to business shall be competent to exercise all powers and discretions for the time being exercisable by the Directors.
 
106.
Questions arising at any meeting of the Directors shall be decided by a majority of votes and each Director shall be entitled to one (1) vote in deciding matters deliberated at any meeting of the Directors.
 
107.
A Director who is in any way, whether directly or indirectly, interested in a contract or proposed contract with the Company shall declare the nature of his interest at a meeting of the Directors. A general notice given to the Directors by any Director to the effect that he is a member of any specified company or firm and is to be regarded as interested in any contract which may thereafter be made with that company or firm shall be deemed a sufficient declaration of interest in regard to any contract so made. A Director may vote in respect of any contract or proposed contract or arrangement notwithstanding that he may be interested therein and if he does so his vote shall be counted and he may be counted in the quorum at any meeting of the Directors at which any such contract or proposed contract or arrangement shall come before the meeting for consideration.
 
108.
A Director may hold any other office or place of profit under the Company (other than the office of auditor) in conjunction with his office of Director for such period and on such terms (as to remuneration and otherwise) as the Directors may determine and no Director or intending Director shall be disqualified by his office from contracting with the Company either with regard to his tenure of any such other office or place of profit or as vendor, purchaser or otherwise, nor shall any such contract or arrangement entered into by or on behalf of the Company in which any Director is in any way interested, be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for any profit realized by any such contract or arrangement by reason of such Director holding that office or of the fiduciary relation thereby established. A Director, notwithstanding his interest, may be counted in the quorum present at any meeting whereat he or any other Director is appointed to hold any such office or place of profit under the Company or whereat the terms of any such appointment are arranged and he may vote on any such appointment or arrangement.
 
109.
Any Director may act by himself or his firm in a professional capacity for the Company, and he or his firm shall be entitled to remuneration for professional services as if he were not a Director; provided that nothing herein contained shall authorize a Director or his firm to act as auditor to the Company.
 
110.
The Directors shall cause minutes to be made in books or loose-leaf folders provided for the purpose of recording:
 
 
(a)
all appointments of officers made by the Directors;
 
 
26


 
 
(b)
the names of the Directors present at each meeting of the Directors and of any committee of the Directors; and
 
 
(c)
all resolutions and proceedings at all meetings of the Company, and of the Directors and of committees of Directors.
 
111.
When the chairman of a meeting of the Directors signs the minutes of such meeting, the same shall be deemed to have been duly held notwithstanding that all the Directors have not actually come together or that there may have been a technical defect in the proceedings.
 
112.
A resolution signed by a majority of the Directors shall be as valid and effectual as if it had been passed at a meeting of the Directors duly called and constituted and when signed, a resolution may consist of several documents each signed by one or more of the Directors.
 
113.
The continuing Directors may act, notwithstanding any vacancy in their body, but if their number is reduced below the number fixed pursuant to these Articles as the necessary quorum of Directors, then the continuing Directors may act only to increase the number or to summon a general meeting of the Company, but for no other purpose.
 
114.
A committee appointed by the Directors may elect a chairman of its meetings. If no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for holding the same, the members present may choose one of their number to be chairman of the meeting.
 
115.
A committee appointed by the Directors may meet and adjourn as it thinks proper. Questions arising at any meeting shall be determined by a majority of votes of the committee members present and in case of an equality of votes the chairman shall have a second or casting vote.
 
116.
All acts done by any meeting of the Directors or of a committee of Directors, or by any person acting as a Director, shall notwithstanding that it be afterwards discovered that there was some defect in the appointment of any such Director or person acting as aforesaid, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and was qualified to be a Director.
PRESUMPTION OF ASSENT
 
117.
A Director who is present at a meeting of the Board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent from such action with the person acting as the chairman or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour of such action.
 
27

DIVIDENDS, DISTRIBUTIONS AND RESERVE
 
118.
Subject to any rights and restrictions for the time being attached to any class or classes of shares and these Articles, the Directors may from time to time declare dividends (including interim dividends) and other distributions on shares in issue and authorize payment of the same out of the funds of the Company lawfully available therefor.
 
119.
Subject to any rights and restrictions for the time being attached to any class or classes of shares and these Articles, the Company by Ordinary Resolution may declare dividends, but no dividend shall exceed the amount recommended by the Directors.
 
120.
The Directors may, before recommending or declaring any dividend, set aside out of the funds legally available for distribution such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for meeting contingencies, or for equalizing dividends or for any other purpose to which those funds may be properly applied and pending such application may, at the like discretion, either be employed in the business of the Company or be invested in such investments (other than shares of the Company) as the Directors may from time to time think fit.
 
121.
Any dividend may be paid by check or wire transfer to the registered address of the Member or person entitled thereto, or in the case of joint holders, to any one of such joint holders at his registered address or to such person and such address as the Member or person entitled, or such joint holders as the case may be, may direct. Every such check shall be made payable to the order of the person to whom it is sent or to the order of such other person as the Member or person entitled, or such joint holders as the case may be, may direct.
 
122.
The Directors when paying dividends to the Members in accordance with the foregoing provisions may make such payment either in cash or in specie.
 
123.
No dividend shall be paid otherwise than out of profits or, subject to the restrictions of the Companies Law, the share premium account.
 
124.
Subject to the rights of persons, if any, entitled to shares with special rights as to dividends, all dividends shall be declared and paid according to the amounts paid or credited as fully paid on the shares, but if and so long as nothing is paid up on any of the shares in the Company dividends may be declared and paid according to the amounts of the shares. No amount paid on a share in advance of calls shall, while carrying interest, be treated for the purposes of this Article as paid on the share.

125.
If several persons are registered as joint holders of any share, any of them may give effectual receipts for any dividend or other monies payable on or in respect of the share.
 
126.
Any dividend unclaimed after a period of six years from the date of declaration of such dividend may be forfeited by the Board of Directors and, if so forfeited, shall revert to the Company.
 
127.
No dividend shall bear interest against the Company.
 
28

BOOK OF ACCOUNTS
 
128.
The books of account relating to the Company’s affairs shall be kept in such manner as may be determined from time to time by the Directors.
 
129.
The books of account shall be kept at such place or places as the Directors think fit, and shall always be open to the inspection of the Directors.
 
130.
The Directors shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors, and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by law or authorized by the Directors or by the Company by Ordinary Resolution.
 
131.
Subject to the requirements of applicable law and the listing rules of the Designated Stock Exchange, the accounts relating to the Company’s affairs shall be audited in such manner and with such financial year end as may be determined from time to time by the Company by Ordinary Resolution or failing any such determination by the Directors or failing any determination as aforesaid shall not be audited.
ANNUAL RETURNS AND FILINGS
 
132.
The Board shall make the requisite annual returns and any other requisite filings in accordance with the Companies Law.
AUDIT
 
133.
The Directors may appoint an Auditor of the Company who shall hold office until removed from office by a resolution of the Directors and may fix his or their remuneration.
 
134.
Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and officers of the Company such information and explanation as may be necessary for the performance of the duties of the auditors.
 
135.
Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next special meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted company, and at any time during their term of office, upon request of the Directors at any general meeting of the Members.
 
29

THE SEAL
 
136.
The Seal of the Company shall not be affixed to any instrument except by the authority of a resolution of the Board of Directors provided always that such authority may be given prior to or after the affixing of the Seal and if given after may be in general form confirming a number of affixings of the Seal. The Seal shall be affixed in the presence of any one or more persons as the Directors may appoint for the purpose and every person as aforesaid shall sign every instrument to which the Seal of the Company is so affixed in their presence.
 
137.
The Company may maintain a facsimile of its Seal in such countries or places as the Directors may appoint and such facsimile Seal shall not be affixed to any instrument except by the authority of a resolution of the Board of Directors provided always that such authority may be given prior to or after the affixing of such facsimile Seal and if given after may be in general form confirming a number of affixings of such facsimile Seal. The facsimile Seal shall be affixed in the presence of such person or persons as the Directors shall for this purpose appoint, and such person or persons as aforesaid shall sign every instrument to which the facsimile Seal of the Company is so affixed in their presence.
 
138.
Notwithstanding the foregoing, a Director shall have the authority to affix the Seal, or the facsimile Seal, to any instrument for the purposes of attesting authenticity of the matter contained therein but which does not create any obligation binding on the Company.
OFFICERS
 
139.
Subject to Article 91, the Company may have Chief Executive Officer, Chief Operating Officer, Chief Technology Officer, Chief Financial Officer, Company Secretary, one or more Vice Presidents, Manager or Controller, appointed by the Directors. The Directors may also from time to time appoint such other officers as they consider necessary, all for such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors from time to time subscribe.
 
30

CAPITALISATION OF PROFITS
 
140.
Subject to the Statutes and these Articles, the Board may, with the authority of an Ordinary Resolution:
 
 
(a)
resolve to capitalize an amount standing to the credit of reserves (including a share premium account, capital redemption reserve and profit and loss account), whether or not available for distribution;
 
 
(b)
appropriate the sum resolved to be capitalized to the Members in proportion to the nominal amount of shares (whether or not fully paid) held by them respectively and apply that sum on their behalf in or towards:
 
 
(i)
paying up the amounts (if any) for the time being unpaid on shares held by them respectively; or
 
 
(ii)
paying up in full unissued shares or debentures of a nominal amount equal to that sum, and allot the shares or debentures, credited as fully paid, to the Members (or as they may direct) in those proportions, or partly in one way and partly in the other, but the share premium account, the capital redemption reserve and profits which are not available for distribution may, for the purposes of this Article, only be applied in paying up unissued shares to be allotted to Members credited as fully paid;
 

 
(c)
make any arrangements it thinks fit to resolve a difficulty arising in the distribution of a capitalized reserve and in particular, without limitation, where shares or debentures become distributable in fractions the Board may deal with the fractions as it thinks fit;
 
 
(d)
authorize a person to enter (on behalf of all the Members concerned) an agreement with the Company providing for either:
 
 
(i)
the allotment to the Members respectively, credited as fully paid, of shares or debentures to which they may be entitled on the capitalization, or
 
 
(ii)
the payment by the Company on behalf of the Members (by the application of their respective operations of the reserves resolved to be capitalized) of the amounts or part of the amounts remaining unpaid on their existing shares, an agreement made under the authority being effective and binding on all those Members; and
 

 
(e)
generally do all acts and things required to give effect to the resolution.

31



NOTICES
 
141.
Except as otherwise provided in these Articles, any notice or document may be served by the Company or by the person entitled to give notice to any Member either personally, by facsimile or by sending it through the post in a prepaid letter or via a recognized courier service, fees prepaid, addressed to the Member at his address as appearing in the Register of Members or, to the extent permitted by all applicable laws and regulations, by electronic means by transmitting it to any electronic number or address or website supplied by the Member to the Company or by placing it on the Company’s Website. In the case of joint holders of a share, all notices shall be given to that one of the joint holders whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to all the joint holders.
 
142.
Notices posted to addresses outside the Cayman Islands shall be forwarded by prepaid airmail.
 
143.
Any Member present, either personally or by proxy, at any meeting of the Company shall for all purposes be deemed to have received due notice of such meeting and, where requisite, of the purposes for which such meeting was convened.
 
144.
Any notice or other document, if served by:
 
 
(a)
post, shall be deemed to have been served five calendar days after the time when the letter containing the same is posted (in proving such service it shall be sufficient to prove that the letter containing the notice or document was properly addressed and duly posted);
 
 
(b)
facsimile, shall be deemed to have been served upon confirmation of receipt;
 
 
(c)
recognized courier service, shall be deemed to have been served 48 hours after the time when the letter containing the same is delivered to the courier service and in proving such service it shall be sufficient to prove that the letter containing the notice or documents was properly addressed and duly delivered to the courier; or
 
 
(d)
electronic means as provided herein shall be deemed to have been served and delivered on the day following that on which it is successfully transmitted or at such later time as may be prescribed by any applicable laws or regulations.
 
145.
Any notice or document delivered or sent to any Member in accordance with the terms of these Articles shall notwithstanding that such Member be then dead or bankrupt, and whether or not the Company has notice of his death or bankruptcy, be deemed to have been duly served in respect of any share registered in the name of such Member as sole or joint holder, unless his name shall at the time of the service of the notice or document, have been removed from the Register of Members as the holder of the share, and such service shall for all purposes be deemed a sufficient service of such notice or document on all persons interested (whether jointly with or as claiming through or under him) in the share.
 
146.
Notice of every general meeting shall be given to:
 
 
32

 
 
(a)
all Members who have supplied to the Company an address for the giving of notices to them;
 
 
(b)
every person entitled to a share in consequence of the death or bankruptcy of a Member, who but for his death or bankruptcy would be entitled to receive notice of the meeting; and
 
 
(c)
each Director and Alternate Director.
No other person shall be entitled to receive notices of general meetings.
 
INFORMATION
 
147.
No Member shall be entitled to require discovery of any information in respect of any detail of the Company’s trading or any information which is or may be in the nature of a trade secret or secret process which may relate to the conduct of the business of the Company and which in the opinion of the Board would not be in the interests of the Members of the Company to communicate to the public.
 
148.
The Board shall be entitled to release or disclose any information in its possession, custody or control regarding the Company or its affairs to any of its members including, without limitation, information contained in the Register of Members and transfer books of the Company.
INDEMNITY
 
149.
Every Director (including for the purposes of this Article any Alternate Director appointed pursuant to the provisions of these Articles) and officer of the Company for the time being and from time to time shall be indemnified and secured harmless out of the assets and funds of the Company against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by him in connection with the execution or discharge of his duties, powers, authorities or discretions as a Director or officer of the Company, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by him in defending (whether successfully or otherwise) any civil proceedings concerning the Company or its affairs in any court whether in the Cayman Islands or elsewhere.
 
150.
No such Director or officer of the Company shall be liable to the Company for any loss or damage unless such liability arises through the willful neglect or default of such Director or officer.

33

FINANCIAL YEAR
 
151.
Unless the Directors otherwise prescribe, the financial year of the Company shall end on December 31st in each year and shall begin on January 1st in each year.
WINDING UP
 
152.
Subject to these Articles, if the Company shall be wound up the liquidator may, with the sanction of an Ordinary Resolution of the Company, divide amongst the Members in specie or kind the whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may for such purpose set such value as he deems fair upon any property to be divided as aforesaid and may determine how such division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the contributories as the liquidator, with the like sanction shall think fit, but so that no Member shall be compelled to accept any shares or other securities whereon there is any liability.
AMENDMENT OF MEMORANDUM AND ARTICLES OF ASSOCIATION AND
NAME OF COMPANY
 
153.
The Company may at any time and from time to time by Special Resolution alter or amend these Articles or the Memorandum of Association of the Company, in whole or in part, or change the name of the Company.
REGISTRATION BY WAY OF CONTINUATION
 
154.
The Company may by Special Resolution resolve to be registered by way of continuation in a jurisdiction outside the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing. In furtherance of a resolution adopted pursuant to this Article, the Directors may cause an application to be made to the Registrar of Companies to deregister the Company in the Cayman Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing and may cause all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation of the Company.

MERGERS AND CONSOLIDATION

155.
The Company may merge or consolidate in accordance with the Companies Law.

156.
To the extent required by the Companies Law, the Company may by Special Resolution resolve to merger or consolidate the Company.
 
34

DISCLOSURE

157.The Directors, or any authorised service providers (including the Officers, the Secretary and the registered office agent of the Company), shall be entitled to disclose to any regulatory or judicial authority, or to any stock exchange on which the Shares may from time to time be listed, any information regarding the affairs of the Company including, without limitation, information contained in the Register of Members and books of the Company.
 
 

 
35
Exhibit B
 
 

AGREEMENT AND PLAN OF MERGER

This AGREEMENT AND PLAN OF MERGER (this "Agreement") is entered into as of November 15, 2017,  by and between China Biotech Holdings Limited, a Delaware corporation ("China Biotech"), and Zhong Yuan Bio-Technology Holdings Limited, an exempted company incorporated under the laws of the Cayman Islands ("Zhong Yuan").

RECITALS

1. The Boards of Directors of each of China Biotech and Zhong Yuan have unanimously determined that it is advisable and in the best interests of their respective shareholders or members to reorganize so that China Biotech will merge with and into Zhong Yuan (the "Merger"), with Zhong Yuan surviving;

2. The respective Boards of Directors of China Biotech and Zhong Yuan have each unanimously approved the Merger, this Agreement, the Plan of Merger (as defined below) and, to the extent applicable, the other transactions described herein, pursuant to which Zhong Yuan will be the surviving company of the Merger, all upon the terms and subject to the conditions set forth in this Agreement and the Plan of Merger, and whereby each issued and outstanding share of common stock, par value US$0.0001 per share, of China Biotech ("China Biotech Common Stock") shall be converted into the right to receive one ordinary share, par value US$0.0001 per share, of Zhong Yuan (a "Zhong Yuan Ordinary Share");

3. The Merger requires, among other things, the approval of this Agreement and the Plan of Merger by the affirmative vote of the holders of a majority of the issued and outstanding shares of China Biotech Common Stock and Zhong Yuan Ordinary Shares; and

4. The parties intend that the Merger qualify as a "reorganization" within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the "Code"), and that this Agreement shall be, and is hereby, adopted as a "plan of reorganization" for purposes of Section 368(a) of the Code.

AGREEMENT

NOW THEREFORE, in consideration of the foregoing and of the covenants and agreements contained herein, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

ARTICLE I
The Merger

Section 1.01.   The Merger .  Subject to the terms and conditions of this Agreement, and in accordance with the Delaware General Corporation Law (the "DGCL") and the Cayman Islands Companies Law (the "CICL"), at the Effective Time (as defined in Section 1.02), China Biotech shall be merged with and into Zhong Yuan in accordance with this Agreement and the Plan of Merger, and the separate corporate existence of China Biotech shall thereupon cease. Pursuant to and simultaneously upon the consummation of the Merger at the Effective Time, in accordance with the DGCL and the CICL, (i) Zhong Yuan shall continue as the surviving company in the Merger (sometimes hereinafter referred to as the "Surviving Company"), (ii) the corporate identity, existence, powers, rights and immunities of Zhong Yuan as the Surviving Company shall continue unimpaired by the Merger, and (iii) Zhong Yuan shall succeed to and shall possess all the assets, properties, rights, privileges, powers, franchises, immunities and purposes, and be subject to all the debts, liabilities, obligations, restrictions and duties of China Biotech, all without further act or deed.
Section 1.02.   Filing Plan of Merger; Effective Time .  As soon as practicable following the satisfaction or, to the extent permitted by applicable law, waiver of the conditions set forth in Article V, if this Agreement shall not have been terminated prior thereto as provided in Section 6.01, Zhong Yuan and China Biotech shall cause a plan of merger (the "Plan of Merger") in the form set out in Annex A to be properly executed and filed with the Registrar of Companies of the Cayman Islands (the "Cayman Registrar") in accordance with the CICL and otherwise make all other filings or recordings as required by the DGCL and the CICL. The Merger shall become effective upon the date on which the Plan of Merger is registered by the Cayman Registrar (or on such later date as may be specified in the Plan of Merger) in accordance with the CICL (the "Effective Time).
 
1

 

ARTICLE II
Memorandum and Articles of Association,
Directors and Officers of Surviving Company, and Certain Representations

Section 2.01.   Name of Surviving Company .  The name of the Surviving Company shall be "Zhong Yuan Bio-Technology Holdings Limited."

Section 2.02.   Memorandum and Articles of Association of Surviving Company .  Prior to the Effective Time, Zhong Yuan will adopt the amended and restated memorandum and articles of association in the form set out in Annex B. Such amended and restated memorandum and articles of association shall serve as the memorandum and articles of association of the Surviving Company until thereafter amended as provided by law and such memorandum and articles of association.

Section 2.03.   Directors of Surviving Company .  From and after the Effective Time, the directors of Zhong Yuan immediately prior to the Effective Time shall be the directors of the Surviving Company, each such director to serve in such capacity until his or her earlier death, resignation or removal or until his or her successor is duly elected or appointed.

Section 2.04.   Officers of Surviving Company .  From and after the Effective Time, the officers of Zhong Yuan immediately prior to the Effective Time shall be the officers of the Surviving Company, each such officer to serve in such capacity until his or her earlier death, resignation or removal or until his or her successor is duly elected or appointed.

Section 2.05.   Directors and Officers of Zhong Yuan.   Immediately prior to the Effective Time, China Biotech, in its capacity as the sole member of Zhong Yuan, agrees to take or cause to be taken all such actions as are necessary to cause at least those persons serving as the directors and officers of China Biotech immediately prior to the Effective Time to be elected or appointed as the directors and officers of Zhong Yuan (to the extent the officers and directors of Zhong Yuan and China Biotech are not already identical), each such person to have the same office(s) with Zhong Yuan (and the same class designations (if any) and committee memberships in the case of directors) as he or she held with China Biotech, with the directors to serve until the earlier of the next meeting of the Zhong Yuan shareholders at which an election of directors is required or until their successors are elected or appointed (or their earlier death, disability or retirement).

Section 2.06.   Representation of China Biotech .  China Biotech hereby represents and warrants that it is the owner of all of the outstanding capital stock of Zhong Yuan, free and clear of any adverse claims.

ARTICLE III
Conversion, Issuance and Repurchase of Shares

Section 3.01.   Effect on Capital Stock .  At the Effective Time, by virtue of the Merger and without any action on the part of the holder of any shares of either China Biotech or Zhong Yuan:

(a)   Conversion of China Biotech Share; Issuance of Zhong Yuan Ordinary Share .  Each issued and outstanding share of China Biotech Common Stock shall be automatically converted into the right to receive one validly issued, fully paid and non-assessable Zhong Yuan Ordinary Share, and Zhong Yuan shall issue to each holder of such right that number of Zhong Yuan Ordinary Shares, credited as fully paid, to which each such holder is entitled. Each treasury share of China Biotech Common Stock shall be automatically converted into a treasury share of Zhong Yuan.
 
2

 

(b)   Cancellation of China Biotech Capital Stock .  The certificates for China Biotech Common Stock exchanged for Zhong Yuan Ordinary Shares will be cancelled.

(c)   Cancellation of Zhong Yuan Ordinary Shares .  The one hundred Zhong Yuan Ordinary Shares that were held by China Biotech prior to the Merger shall be cancelled, and no consideration shall be paid or payable to the holder of such Zhong Yuan Ordinary Shares.

(d)   Stock-Based Compensation Plans .  China Biotech shall assign, and Zhong Yuan shall assume, China Biotech's rights and obligations under the stock-based benefit and compensation plans and programs and agreements providing for the grant or award of restricted stock, stock units, stock options, stock appreciation rights, performance shares, performance units, dividend equivalent rights and share awards to the employees, directors and consultants of China Biotech and its affiliates (collectively, the "Stock Plans") in accordance with Article IV of this Agreement. To the extent a Stock Plan provides for awards of incentive stock options pursuant to Section 422 of the Code, approval of such plan by China Biotech, as the sole shareholder of Zhong Yuan, shall be deemed, as of the Effective Time, to constitute approval of the members of Zhong Yuan for purposes of Section 422(b) of the Code.

(e)   Convertible Securities .  China Biotech shall assign, and Zhong Yuan shall assume, China Biotech's rights and obligations under its securities, including but not limited to convertible debentures, warrants and options, that may be convertible into or exercisable into China Biotech Common Stock.

Section 3.02.   Exchange of Zhong Yuan Shares.

(a)   Uncertificated Shares .  At the Effective Time, each outstanding share of China Biotech Common Stock held in uncertificated, book entry form will be exchanged for one Zhong Yuan Ordinary Share in accordance with Sections 3.01(a) and (b) without further act or deed by the holder thereof, and record of such ownership shall be kept in uncertificated, book entry form in China Biotech 's register of members by Zhong Yuan.

(b)   Certificated Shares .  At the Effective Time, each outstanding share of China Biotech Common Stock held in certificated form will be converted into the right to receive one Zhong Yuan Ordinary Share in accordance with Sections 3.01(a) and (b) without further act or deed by the holder thereof, and the holder thereof will cease to be, and will have no rights as, a stockholder of China Biotech. Following the consummation of the Merger, China Biotech will send a letter of transmittal to each such holder, explaining the procedure for surrendering such holder's China Biotech Common Stock certificates in exchange for share certificates representing Zhong Yuan Ordinary Shares.

(c)   Shareholder Rights at Effective Time .  At the Effective Time, holders of China Biotech Common Stock will cease to be, and will have no rights as, stockholders of China Biotech, other than the right to receive any dividend or other distribution with a record date prior to the Effective Time that may have been declared or made by China Biotech on such shares of China Biotech Common Stock in accordance with the terms of this Agreement or prior to the date of this Agreement and that remain unpaid at the Effective Time. After the Effective Time, there shall be no further registration of transfers on the stock transfer books of the Surviving Company of the shares of China Biotech Common Stock that were outstanding immediately prior to the Effective Time. Upon and after the Effective Time, registered shareholders in Zhong Yuan's register of members will have and be entitled to exercise any voting and other rights with respect to and to receive any dividend and other distributions upon Zhong Yuan Ordinary Shares registered in their respective names in the register of members.

Section 3.03.   Dissenters' Rights .   Zhong Yuan members have dissenters' rights in connection with the Merger under the CICL. China Biotech is the sole member of Zhong Yuan.

China Biotech shareholders have appraisal rights in connection with the Merger under the DGCL, unless they have voted in favor of the Merger or consented to the Merger in writing. China Biotech shall notify any shareholder who is entitled to appraisal rights of the approval of the Merger and that appraisal rights are available, and shall furnish such shareholder with a copy of the relevant section of the Delaware General Corporation Law which sets forth the procedure for demanding an appraisal of the shareholder's shares.
 
3

 

ARTICLE IV
Employee Benefit and Compensation Plans and Agreements; Other Contracts
 
Section 4.01.   Assumption of Equity Plans .  At the Effective Time, China Biotech shall assign, and Zhong Yuan shall assume, the rights and obligations of China Biotech under each Stock Plan. To the extent any Stock Plan or any applicable agreement relating thereto provides for the issuance, delivery or purchase of, or otherwise relates to, China Biotech Common Stock, from and after the Effective Time, such Stock Plan or applicable agreement shall be deemed to have been amended to provide for the issuance, delivery or purchase of, or otherwise relate to, Zhong Yuan Ordinary Shares, and all options or awards issued, or benefits available or based upon the value of a specified number of shares of China Biotech Common Stock, under such Stock Plan after the Effective Time shall entitle the holder thereof to purchase, receive, acquire, hold or realize the benefits measured by the value of, as appropriate, an equivalent number of Zhong Yuan Ordinary Shares in accordance with the terms of such Stock Plan and any applicable agreement relating thereto. The outstanding options or other awards or benefits available under the terms of the Stock Plans at and following the Effective Time shall, to the extent permitted by law and otherwise reasonably practicable, otherwise be exercisable, payable, issuable or available upon the same terms and conditions as under such Stock Plans and the agreements relating thereto immediately prior to the Effective Time. Other than as set forth above, the Merger will not affect the underlying terms or conditions of any outstanding equity awards, which shall remain subject to their original terms and conditions.

Section 4.02.   Assumption of Benefit Plans .  At the Effective Time, the obligations of China Biotech under or with respect to every plan, trust, program and benefit then in effect or administered by China Biotech for the benefit of the directors, officers and employees of China Biotech or any of its subsidiaries (collectively, the "Assumed Benefit Plans" and, together with the Assumed Equity Plans, the "Assumed Plans") shall become the lawful obligations of Zhong Yuan and shall be implemented and administered in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated. Effective at the Effective Time, Zhong Yuan hereby expressly adopts and assumes all obligations of China Biotech under the Assumed Plans.

Section 4.03.   Assumption of Contracts .  At the Effective Time, the obligations of China Biotech under or with respect to contracts or agreements (collectively, the "Assumed Contracts") shall become the lawful obligations of Zhong Yuan and shall be performed in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated. Effective at the Effective Time, Zhong Yuan hereby expressly adopts and assumes all obligations of China Biotech under the Assumed Contracts.

Section 4.04.   Other Actions .  Such amendments or other actions that are deemed necessary or appropriate by China Biotech and Zhong Yuan to effect the Merger, including to facilitate the assumption by Zhong Yuan of the Assumed Plans and the Assumed Contracts, and any other amendments or actions that China Biotech and Zhong Yuan shall deem advisable, shall be adopted and entered into with respect to the Assumed Plans, the Assumed Contracts and any other change in control arrangements between the China Biotech and its executive officers and key employees.

ARTICLE V
Conditions Precedent
 
The respective obligations of each party to effect the Merger are subject to the satisfaction or waiver of the following conditions:

(a)   Stockholder Approval .  This Agreement shall have been adopted and approved by the affirmative vote of holders owning a majority of the issued and outstanding shares of China Biotech Common Stock entitled to vote thereon in accordance with the provisions of the Delaware General Corporations Law, and by a Special Resolution of Zhong Yuan in accordance with the provisions of the Cayman Islands Companies Law.

(b)   No Prohibition .  None of the parties hereto shall be subject to any decree, order or injunction of any court of competent jurisdiction, whether in the U.S., the Cayman Islands or any other country that prohibits the consummation of the Merger.
 
 
4

 
(c)   Consents and Authorizations .  Other than the filing of the Plan of Merger provided for under Article I, all material consents and authorizations of, filings or registrations with, and notices to, any governmental or regulatory authority required of China Biotech, Zhong Yuan or any of their respective subsidiaries to consummate the Merger and the other transactions contemplated hereby, including, without limitation, any filings required under (i) applicable U.S. state securities and "Blue Sky" laws, and (ii) applicable Cayman Islands securities laws, shall have been obtained or made.

(d)   Representations and Warranties .  The representations and warranties of the parties set forth herein shall be true and correct in all material respects, and the covenants of the parties set forth herein (other than those to be performed after the Effective Time) shall have been performed in all material respects.


ARTICLE VI
Termination, Amendment and Waiver

Section 6.01.   Termination .  This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after approval by the stockholders of China Biotech, by action of the Board of Directors of China Biotech.

Section 6.02.   Effect of Termination .  In the event of termination of this Agreement as provided in Section 6.01, this Agreement shall forthwith become void and have no effect, without any liability or obligation on the part of China Biotech or Zhong Yuan.

Section 6.03.   Amendment .  This Agreement may be amended by the parties hereto at any time before or after any required approval or adoption by the stockholders of China Biotech of this Agreement or matters presented in connection with this Agreement; provided, however, that after any such approval or adoption, there shall be made no amendment requiring further approval or adoption by such stockholders under applicable law until such further approval or adoption is obtained. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties hereto.

Section 6.04.   Waiver .  At any time prior to the Effective Time, the parties may waive compliance with any of the agreements or covenants contained in this Agreement, or may waive any of the conditions to consummation of the Merger contained in this Agreement. Any agreement on the part of a party to any such waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. The failure of any party to this Agreement to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights.

ARTICLE VII
Covenants

Section 7.01.   Rule 16b-3 Approval .  China Biotech and Zhong Yuan shall take all such steps as may reasonably be required to cause the transactions contemplated by Section 3.01 and any other dispositions of China Biotech equity securities (including derivative securities) or acquisitions of Zhong Yuan equity securities (including derivative securities) in connection with this Agreement by each individual who (i) is a director or officer of China Biotech, or (ii) at the Effective Time, is or will become a director or officer of Zhong Yuan, to be exempt under Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

Section 7.02.   Zhong Yuan Vote .  Prior to or concurrent with seeking the approval and adoption of this Agreement by the stockholders owning a majority of the outstanding shares of China Biotech Common Stock, China Biotech, in its capacity as the sole shareholder of Zhong Yuan, shall pass shareholder resolutions of Zhong Yuan which approve and adopt this Agreement and which approve and authorize the Merger and the Plan of Merger.
Section 7.03.   Further Assurances .  Zhong Yuan shall use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary and reasonably appropriate to consummate and make effective, in the most expeditious manner practicable, the Merger and the other transactions provided for herein.
 
5

 

ARTICLE VIII
General Provisions

Section 8.01. Assignment; Binding Effect; Benefit . Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other party. Subject to the preceding sentence, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. Notwithstanding anything contained in this Agreement to the contrary, except for the provisions of Article IV (collectively, the "Third Party Provisions"), nothing in this Agreement, expressed or implied, is intended to confer on any person other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement. The Third Party Provisions may be enforced only by the specifically intended beneficiaries thereof.

Section 8.02.   Entire Agreement .  This Agreement and any documents delivered by the parties in connection herewith constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings among the parties with respect thereto.

Section 8.03.   Governing Law .  To the fullest extent permitted by law, this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to its rules of conflict of laws.

Section 8.04.   Counterparts .  This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all of the parties hereto.

Section 8.05.   Headings .  Headings of the Articles and Sections of this Agreement are for the convenience of the parties only and shall be given no substantive or interpretative effect whatsoever.

Section 8.06.   Severability .  If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement.

IN WITNESS WHEREOF, China Biotech and Zhong Yuan have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first written above.

CHINA BIOTECH HOLDINGS, INC.


By:_______________________________________________________________________________________________
CHANG Ting Ting, Director


ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED


By:  ________________________________________________
TANG Yau Sing

6

Annex A
  
Form of Plan of Merger
  
The Companies Law (2016 Revision) of the Cayman Islands
  
Plan of Merger

This plan of merger (the "Plan of Merger") is made on ____________, 2017 between China Biotech Holdings, Inc. (the "Merging Company") and Zhong Yuan Bio-Technology Holdings Limited (the "Surviving Company").

Whereas the Surviving Company is a Cayman Islands exempted company and is entering into this Plan of Merger pursuant to the provisions of Part XVI of the Companies Law (2016 Revision) (the "Statute").

Whereas the Merging Company is a Delaware corporation and is entering into this Plan of Merger pursuant to the provisions of Part XVI of the Statute.

Whereas the directors of the Merging Company and the directors of the Surviving Company deem it desirable and in the commercial interests of the Merging Company and the Surviving Company, respectively, that the Merging Company be merged with and into the Surviving Company and that the undertaking, property and liabilities of the Merging Company vest in the Surviving Company (the "Merger").

Terms not otherwise defined in this Plan of Merger shall have the meanings given to them under the Agreement and Plan of Merger dated effective as of November 15, 2017 and made between the Surviving Company and the Merging Company (the "Merger Agreement") a copy of which is annexed at Annexure 1 hereto.

Now therefore this Plan of Merger provides as follows:

1.   The constituent companies (as defined in the Statute) to this Merger are the Surviving Company and the Merging Company.

2.   The surviving company (as defined in the Statute) is the Surviving Company.

3.  The registered office of the Surviving Company is c/o Vistra (Cayman) Limited, P. O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KYI – 1205 Cayman Islands and the registered office of the Merging Company is c/o Inc. Plan (USA), Trolley Square, Suite 20C, Wilmington, Delaware  19806.

4.   Immediately prior to the Effective Date (as defined below), the share capital of the Surviving Company will be US$50,000 divided into 500,000,000 ordinary shares of a par value of US$0.0001 each, and the Surviving Company will have one hundred ordinary shares in issue.

5.   Immediately prior to the Effective Date (as defined below), the share capital of the Merging Company will be US$10,000 divided into 100,000,000 shares of common stock with a par value of US$0.0001, and the Merging Company will have 8,500,000 shares of common stock in issue.

6.   It is intended that the Merger is to take effect on that date on which this Plan of Merger is registered by the Registrar (the "Effective Date").

7.   The terms and conditions of the Merger are such that, on the Effective Date:

7.1  each share of common stock issued and outstanding in the Merging Company on the Effective Date shall be converted into or exchanged for one ordinary share in the Surviving Company (which shall be issued by the Surviving Company credited as fully paid) and each ordinary share issued and outstanding in the Surviving Company immediately prior to the Effective Date shall be cancelled, and no consideration shall be paid or payable to the holder of such share.
 
A-1

 
8.   The rights and restrictions attaching to the shares in the Surviving Company are set out in the Memorandum and Articles of Association of the Surviving Company in the form annexed at Annexure 2 hereto.
9.   There are no amounts or benefits which are or shall be paid or payable to any director of either constituent company or the Surviving Company consequent upon the Merger.
10.   The Surviving Company has granted no fixed or floating security interests that are outstanding as at the date of this Plan of Merger.
11.   The names and addresses of each director of the Surviving Company (as defined in the Statute) are:
11.1  TANG Yau Sing, Room B, 10/F, Azura, 2A Seymour Road, Mid-Level, Hong Kong

12.   This Plan of Merger has been approved by the board of directors of the Surviving Company pursuant to section 233(3) of the Statute.

13.   This Plan of Merger has been authorised by the sole shareholder of the Surviving Company pursuant to section 233(6) of the Statute.
14.   All necessary approvals have been obtained from the shareholders, officers and management of the Merging Company pursuant to the Delaware General Corporate Law.
15.   At any time prior to the Effective Date, this Plan of Merger may be:
15.1   terminated by the board of directors of either the Surviving Company or the Merging Company;
15.2   amended by the board of directors of both the Surviving Company and the Merging Company to:
 (a)   change the Effective Date provided that such changed date shall not be a date later than the ninetieth day after the date of registration of this Plan of Merger with the Registrar of Companies; and
 (b)   effect any other changes to this Plan of Merger which the directors of both the Surviving Company and the Merging Company deem advisable, provided that such changes do not materially adversely affect any rights of the shareholders of the Surviving Company or the Merging Company, as determined by the directors of both the Surviving Company and the Merging Company, respectively.
16.   This Plan of Merger may be executed in counterparts.
17.   This Plan of Merger shall be governed by and construed in accordance with the laws of the Cayman Islands.
In witness whereof the parties hereto have caused this Plan of Merger to be executed on the day and year first above written.
 
Duly authorized for and on behalf of
China Biotech Holdings Limited
 
Duly authorized for and on behalf of
Zhong Yuan Bio-Technology Holdings Limited
 
 
 
 
 
 
CHANG Ting Ting, Director
 
TANG Yau Sing, Director
 

 
 
 
 
 
 
A-2

Annexure 2
  
Amended and Restated Memorandum and Articles of Association
  
 
 
 
 

A-3